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Abstract 
The mitochondrial leucyl-tRNA synthetase (mtLeuRS) of certain Caenorhabditis 
species contains an idiosyncratic C-terminal addition. Bioinformatic analyses identified 
this domain in the mtLeuRS and also four putative nuclear localization sequences (NLSs) 
encoded within the domain. This C-terminal extension of Caenorhabditis mitochondrial 
LeuRS, or CECL domain, is highly positively charged and shows no obvious homologs 
in protein databases. Bioinformatic and computational modeling suggest that CECL is an 
added domain rather than being a part of the canonical C-terminal domain. An annotated 
splice-variant of the mitochondrial LeuRS hints at a mechanism for subcellular 
localization. Deletion of CECL from the chromosome prevents homozygous worms from 
surviving fertilization in most cases. From these observations, we hypothesize that the 
mitochondrial LeuRS of C. elegans performs an alternate nuclear function, perhaps 
carried out specifically in the neurons of the animal.  
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Chapter 1 
The C-terminal Extension of Caenorhabditis Mitochondrial LeuRS: A Novel LeuRS 
Domain 
 
Introduction  
Aminoacyl-tRNA synthetases (aaRSs) are an essential family of enzymes that 
aminoacylate tRNA in the first step of protein synthesis (Söll & Schimmel, 1974). The 
aminoacylation reaction occurs in two steps: first, an ATP is consumed to activate an 
amino acid with AMP, resulting in the release of inorganic pyrophosphate (Fersht & 
Kaethner, 1976). In the second step, the aminoacyl-adenylate is transferred to the 3’ end 
of the tRNA molecule (Fersht & Kaethner, 1976). After aminoacylation, the 3’-end of the 
aminoacyl-tRNA is then transferred to from the synthetic active site to an editing site 
called the Connective Peptide 1 (CP1) domain, where mischarged amino acids are 
hydrolyzed from the tRNA molecule (Fersht & Dingwall, 1979). 
These housekeeping proteins also carry out numerous non-canonical functions 
that are distinct from producing aminoacyl-tRNA (Guo & Schimmel, 2013; Martinis, 
1999). For example, the eukaryotic leucyl-tRNA synthetase (LeuRS) specifically doubles 
as an intracellular leucine sensor in the (m)TORC1 signaling pathway (Bonfils et al., 
2012; Han et al., 2012). In yeast, mitochondrial LeuRS facilitates splicing of essential 
respiratory genes (Labouesse, 1990; Labouesse, Dujardin, & Slonimski, 1985). These 
secondary functions can originate within the canonical architecture of the synthetase.  In 
addition, they can be conferred by manipulating the protein via a splice-variant, 
proteolytic fragment, or post-translational modification. Alternatively, some aaRSs 
acquire new activities through domain additions (Guo & Schimmel, 2013; Han et al., 
2012) (Lo et al., 2014; Sajish & Schimmel, 2015; Z. Wei et al., 2016). 
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Alternative functions of certain aaRSs are performed by targeting the proteins or 
their fragments to different tissues or parts of the cell. Many cytoplasmic aaRSs have 
been found to localize to the nucleus. EPRS, for example, silences the translation of 
ceruloplasmin (Sampath et al., 2004). GluRS (Galani, Grosshans, Deinert, Hurt, & 
Simos, 2001), MetRS plays a role in biogenesis of rRNA in the nucleolus (Galani et al., 
2001; Ko, Kang, Kim, Park, & Kim, 2000). LysRS regulates gene expression involved in 
immune response (Yannay-Cohen et al., 2009). SerRS is involved in the development of 
the closed circulatory system in vertebrates through VEGFA regulation (Xu et al., 2012), 
TrpRS forms a complex in the nucleus which activates PARP1 (Sajish et al., 2012). 
Oxidative stress targets TyrRS to the nucleus, where it upregulates the expression of 
DNA repair genes such as BRCA1 and RAD51 (N. Wei et al., 2014).   
A previous study on the mitochondrial LeuRS showed heightened expression in 
the nerve ring and axons that serve the body wall muscle of C. elegans. (Lee et al., 2003). 
Up-regulation of mtLeuRS expression in the body wall muscle is unsurprising given the 
mitochondrial demands of muscle. In contrast, up-regulation in the head neurons 
specifically is striking. It is believed that tRNA synthetases performing alternate 
functions are up-regulated by the cell, so as to sustain protein synthesis and partition 
additional enzyme or enzyme fragment to an alternate function. We hypothesize that the 
head neurons may be the location of an alternate function of the mitochondrial LeuRS.  
The cytoplasmic LeuRS (cLeuRS) also has been implicated in performing double-
duty. In addition to aminoacylating cytoplasmic tRNAs the cytoplasmic LeuRS (cLeuRS) 
also serves as a leucine sensor on the mammalian Target of Rapamycin Complex 1 
(mTORC1) pathway (Bonfils et al., 2012; Han et al., 2012). The cLeuRS, like many 
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cytoplasmic LeuRSs of higher eukaryotes, also contains a unique C-terminal extension 
called the unique to LeuRS domain, or UNE-L domain (Guo, Yang, & Schimmel, 2010). 
The UNE-L domain has been implicated in the anchoring of the cLeuRS to the multi-
synthetase complex (MSC) in eukaryotes (Ling et al., 2005). It is believed that the cell 
anchors aaRSs to the MSC as a way to partition aaRSs protein synthesis function from 
their alternate functions (Galani et al., 2001).  
The mtLeuRS of Caenorhabditis also contains a unique extension with an 
abundance of lysine and arginine residues. The addition of this domain suggests a 
possible alternate function performed by the mtLeuRS. The lysine and arginine residues 
indicate the possibility of nuclear targeting of this synthetase through the use of a splice-
variant. The up-regulation of mtLeuRS expression in the head neurons suggests the 
possibility of an alternate neuronal function for mtLeuRS.  
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Methods  
 
Computation 
Protein sequences for bioinformatics analysis were retrieved from GenBank and 
UniProt and aligned using MUSCLE.  
Candidates for computational modeling were chosen from the BLAST results 
against proteins of known structure by choosing sequences best similarity, indicated by 
the lowest E value. The two structures with the best similarity to C. elegans LeuRS were 
LeuRSs from E. coli (4AQ7) and T. thermophilus (2V0C). The Modeller plugin was used 
to map the C. elegans mitochondrial LeuRS onto the aligned sequences of the two 
bacterial structures. Of the five models generated, the model with the lowest zDOPE 
(0.45) was chosen to best depict the C. elegans mitochondrial LeuRS. The structure of 
E. coli tRNALeu was docked to the newly generated model for reference. 
 
Computational modeling of C. elegans UNE-L and CECL 
Results from BLAST searches did not identify meaningful candidates for which to 
model C. elegans UNE-L and CECL. Using HHPred 
(https://toolkit.tuebingen.mpg.de/hhpred), I obtained candidates to model these domains 
separate from the rest of the LeuRS protein. The HHPred uses a different set of 
constraints from BLAST and is able to generate models based on a greater number of 
samples with smaller regions of homology. Three candidates were chosen with 
probability scores >55 (PDB structures: 2ABY, 1TIG, and 2Y7C) to model the N-terminal 
region of CECL. One candidate chosen with a probability score of ~40 (4IPA) was used 
to model the C-terminal region of CECL. These candidates were then modeled using the 
Modeller plugin from UCSF Chimera (https://www.cgl.ucsf.edu/chimera/) and the 
structure with the lowest estimated RMSD was chosen to depict each domain.  
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Cloning 
Primers were designed manually and analyzed by NEB Tm Calculator 
(tmcalculator.neb.com/). All primers (shown in Table 4) were ordered from Integrated 
DNA Technologies (IDT). Polymerase Chain Reaction (PCR) samples contained 0.2 
ng/µL plasmid DNA or 2 ng/uL genomic DNA, 500 nM each of forward and reverse 
primers, 200 µM of each dNTP, commercial reaction buffer diluted to 1x, 2 mM MgCl2, 
0.025 U/µL GoTaq Green/Pfu polymerases (Promega) or 0.02 U/µL KOD Xtreme DNA 
polymerase (EMD Millipore).  
Vector backbones for E. coli expression or codon-optimized templates was done 
using by performing PCR using the TAQ STANDARD profile (Table 1) and GoTaq Green 
(Promega) or KOD Xtreme DNA Polymerases (EMD Millipore). PCR for any reaction 
using DNA from C. elegans origin was done using LOW RUN profile (Table 2). Amplified 
DNA from the PCR reactions were purified using Machery Nagel NucleoSpin Gel and 
PCR Cleanup Kit (Clontech # 740609.50). The isolated DNA product was digested for 
two hours with 2 U DpnI at 37°C for 1 hour to remove the original template DNA. 
 
Table 1: Thermal cycler conditions used for PCR:  TAQ STANDARD PCR Profile 
Temperature (˚C) Time Repeats 
95° 90 Seconds  
95° 30 Seconds 
Repeat 10-35x 52° 20 Seconds 
72° 60 Seconds / 1kb of DNA 
72° 10 minutes  
 
Table 2: Thermal cycler conditions used for PCR:  LOW RUN PCR Profile 
Temperature (˚C) Time Repeats 
95° 90 Seconds  
95° 30 Seconds 
Repeat 10-35X 52° 10 Seconds 48° 10 Seconds 
60° 90 Seconds / 1kb of DNA 
72° 10 minutes  
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Gibson Assembly reactions (NEB) were performed with 1 µmol insert DNA, 0.1 
µL backbone DNA, (primers for each reaction shown in Table 4) and 10 µL Gibson 
Assembly Master Mix (NEB# E2611) in a total volume of 20 µL. Reactions were 
incubated in a thermal cycler at a constant temperature of 50°C for 1 hour. The DNA 
from the Gibson Assembly reaction was used to transform E. coli cells. In particular, the 
cells were incubated on ice for 10 minutes, followed by a 1 hour ice incubation in the 
presence of 1 µL Gibson Assembly reaction mixture. The cells were then incubated at 
42°C for 45 seconds and placed on ice for three minutes before addition of 950 µL SOC 
broth and incubation on a shaker at 37°C for 1 hour before being plated on solid media 
containing appropriate selective antibiotics. Successful clones were identified by colony 
PCR using flanking primers and PCR profile compatible with the organism source and 
confirmed by DNA sequencing (UIUC Core Sequencing Facility).  
 
Protein Production and Purification 
A colony of an E. coli expression strain containing the plasmid of interest was 
selected from solid media and used to inoculate a 3 mL overnight culture of LB with the 
appropriate selective antibiotics. The entire starter culture was then used to inoculate a 
1-4 L flask of LB and allowed to grow to OD600 0.5-1.0 before being induced with 0.4 µM 
Isopropyl β-D-1-thiogalactopyranoside (IPTG). Induced cultures were incubated 12-16 
hours at a temperature of 16°C-25°C. Cells were harvested by centrifugation using a 
Beckman Avanti J-E centrifuge.  
Cells expressing proteins that contained six-histidine tags were resuspended in 
10 mL HA-1 buffer (10 mM Tris-HCl, 20 mM sodium phosphate, pH 8.0, 100 mM NaCl, 
5% glycerol) that contained 10 µM phenylmethylsulfonyl fluoride (PMSF) per liter of 
culture. Cells were immediately lysed by French Press. Lysate was then centrifuged at 
12,000 RPM for 30 minutes at 4°C.  
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To prepare the resin, 0.5 mL Ni-NTA (Sigma Aldrich) per liter of culture was 
equilibrated by adding 20 column volumes of HA-1 buffer and centrifuging in a clinical 
centrifuge at maximum speed. Supernatant was removed and the process repeated two 
additional times. Supernatant was then transferred to a conical tube containing the 
equilibrated resin and placed on a nutator at 4 °C for 1 hour. The slurry was then placed 
in a column, and washed with 100 column volumes of HA-2 (10 mM Tris-HCl, 20 mM 
sodium phosphate, pH 7.0, 500 mM NaCl, and 5% glycerol). Protein was eluted with 20 
column volumes of HA-1 that contained 200 mM imidazole. Purification steps were 
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
before being dialyzed and concentrated using Amicon Ultra filter units (EMD Millipore).  
Cells expressing proteins containing a glutathione s-transferase (GST) tag were 
resuspended in 10 mL equilibration buffer (50 mM Tris, 150 mM NaCl, pH 8.0) per liter of 
culture and lysed as described above. To prepare the resin, 0.5 mL GST resin (Sigma 
Aldrich) per liter of culture was equilibrated by adding 20 column volumes equilibration 
buffer and centrifuging in a clinical centrifuge at max speed. The supernatant was 
removed and the process was repeated two additional times. Supernatant was then 
transferred to a conical tube containing the equilibrated resin and placed on a nutator at 
4°C for 1 hour. The slurry was then placed on a column, and washed with 100 column 
volumes of Equilibration Buffer. Protein was eluted with 20 column volumes of Elution 
Buffer (Equilibration Buffer + 20mM Reduced Glutathione. Purification and concentration 
steps were the same as for Ni-NTA purification. 
 
Growth and maintenance of C. elegans 
Unless otherwise noted, worms were grown at 20°C on solid NGM media (3 g/L 
NaCl, 2.5 g/L peptone, 17 g/L agar, 0.1 M CaCl2, 0.1M Mg2SO4, 25 mM KPO4 buffer, and 
100µg/mL ampicillin. The plates were seeded with a lawn of OP-50 bacteria (a uracil 
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auxotrophic strain, used to prevent bacterial overgrowth) containing an empty pUC19 
vector to confer ampicillin resistance. The lawn was grown overnight at 20°C. Worms 
were then transferred to the bacterial lawn using a worm pick (flattened platinum wire 
held in the broken tip of a Pasteur pipette, sealed by the flame of a Bunsen burner). 
Every two to four days, 6-10 worms of each strain were passaged to fresh NGM plates.  
Animals on plates contaminated by mold were washed off the plate with water 
and allowed to settle to the bottom of a microcentrifuge tube. Supernatant was removed 
and replaced with 20% bleach and 1 M NaOH in order to remove all mold, leaving 
behind only the unhatched eggs. The tube containing the worms in the bleach mixture 
was mixed every minute for ten minutes. The tubes were then spun at low speed in a 
tabletop mini centrifuge. The supernatant was removed and replaced three times with 1 
mL water to wash the remaining eggs. The eggs were resuspended in 100 µL M9 buffer 
(42 mM Na2HPO4, KH2PO4, 86 mM NaCl, 1 mM Mg2SO4). Synchronization of a worm 
culture can be achieved at this step by waiting 12-16 hours to plate resuspended worms. 
Synchronization was typically used to generate large amounts of young adult worms for 
transgenics.  
 
C. elegans transgenics 
Needles for microinjection were pulled from a glass capillary tube with an internal 
glass filament (World Precision Instruments# TW100F-4) on a Sutter Instruments P-97 
with a trapezoid filament. The settings used to pull the needles were Pressure=500, 
Heat=480, Pull=250, Velocity=10, and Time=200. This setting with the current filament 
gives a quick taper to a sharp point, also called a “bee stinger” needle.  
Microinjection needles were back-loaded with DNA mixture that included 5 ng/µL 
pCFJ90 (Erik Jorgensen, addgene plasmid #19327), 5-20 ng/µL of plasmid construct 
and up to 100 ng/µL sheared, blunt-ended C. elegans chromosomal DNA), and taped to 
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the wall to allow the mixture to settle into the needle. A coverslip was broken and placed 
on a 5% agarose pad made on another coverslip and covered with Halocarbon 700 Oil 
(Sigma# H8898). Prior to injection, the agarose pad was dried in an oven at 80°C for 15 
minutes so that the body of the animal sticks to the pad. The coverslips were mounted 
on the stage of the injection scope (Nikon Eclipse TE2000-S) and the lens focused on 
the edge of the broken slip.  
To open the needle at the end, the needle was dragged along the coverslip while 
slight pressure was applied to the microinjector until liquid flowed freely out of the tip of 
the needle. Next, a young-adult worm was selected from an NGM plate and placed into 
the halocarbon oil. A human eyelash was used to depress the entire length of the 
animal’s body onto the agar and immobilize the worm. The needle worm was placed on 
the stage so that the injection needle will be on the same side as the syncytial gonad, 
opposite the vulva. The microscope was focused on the syncytial gonad so that two rows 
of nuclei could be seen on either side of the syncytium. The needle was then brought 
into focus by moving it into the same plane as the two rows of nuclei and pressed 
against the cuticle of the worm. By gently tapping the micromanipulator, the needle 
entered the gonad and the DNA mixture injected. If the needle was properly placed, the 
gonad expanded lightly in contrast to the rest of the animal, which does not expand, 
indicating proper injection location. As needed to prevent dessication of the animal, a 
small amount of DNA mixture was used to wet the worm. The agar pad with the injected 
worm was removed quickly from the stage and 10 µL of recovery buffer (5 mm 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.2, 3 mM CaCl2, 3 mM 
MgCl2, 66 mM NaCl, 2.4 mM KCl, and 4% glucose) was used to free the worm from the 
agar pad. The agar pad was then placed in a humidity chamber (pipette tip box with a 
wet paper towel) and allowed to sit for at least 10 minutes while the worm recovers and 
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equilibrates in the recovery buffer. The worms were then transferred to a fresh NGM 
plate. A drop of recovery buffer was placed on the lawn of the new NGM plate and an 
eyelash was used to gently pick up the worm from the drop of recovery buffer from the 
agar pad and placed in the drop on the NGM plate, while minimizing transfer of 
Halocarbon 700 oil. The next morning, all injected worms were transferred to separate 
NGM plates and left to lay eggs, which usually happened within 24 hours. When the 
hatched animals reached the second larval stage, they were screened using a 
fluorescence dissecting scope. Worms injected with pCFJ90 (Pmyo-2 driving mCherry 
expression) fluoresced red in the pharynx (Erik Jorgensen, addgene plasmid #19327). 
Red-fluorescing worms were then transferred to their own plates and allowed to 
reproduce. The F2 generation was then screened for fluorescence, indicating that a 
stable line has been produced.  
Generation and maintenance of ∆CECL mutants 
Mutant worm strains lacking the CECL domain were generated using CRISPR-
Cas 9. In collaboration with Knudra (knudra.com), I designed two sgRNA templates( 5’ 
GAAGAGAACCGCAAGAAAAT-3’ and 5’- AGCTACACGATAGAGTTACG-3’) that 
targeted the Cas9 nuclease to the CECL-encoding region of the mtLeuRS gene. The 
sgRNA templates were co-injected with the Cas9 nuclease mRNA by Knudra, who also 
screened for mutants.  
A BsaAI site (5’-YACGTR-3’) was disrupted in all three ∆CECL mutants, allowing 
an easy way to test for the presence of CECL based on the presence of this restriction 
site. Wild-type worms have a BsaAI restriction site located near the two sequences of 
the sgRNAs that target disruption of that region. To determine if the CECL region had 
been disrupted, a primer pair (5’-CAC ACG TCG CTT CCG AAA TGT GG-3’ and 5’- CCT 
CTT TCC ACC TTT CTT CCC GAT TTC CAA C-3’) flanking the BsaAI site was used in a 
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50 µL PCR reaction, which was then digested at 37°C by 5 U of BsaAI in 1x Cutsmart 
Buffer (NEB) and electrophoresed on a 1.5% agarose gel. A band at approximately 300 
base pairs (depending on the mutant) corresponded to the ∆CECL allele, whereas two 
bands at about 170bp and 130bp corresponded to a WT CECL allele, indicating 
successful cleavage by BsaAI. 	
Since ∆CECL was homozygous lethal, the worms had to be passaged twice a 
week in order to maintain the presence of the ∆CECL allele. Mutant worms that were 
missing the CECL domain grew most optimally at low temperatures of 16°C. After 
confirming the presence of worms with ∆CECL alleles on a plate, six animals were 
transferred to individual plates and allowed to lay eggs. The parent worm was then 
subjected to single-worm PCR by first adding the worm to 10 µL lysis buffer (10 mM Tris 
pH 8.3, 50 mM KCl, 2.5mM MgCl2, 0.45% NP-40, 0.45% Tween20, 0.01% Gelatin) that 
included 0.2 µg/µL Proteinase K added fresh before use. The mixture was incubated in a 
thermal cycler using the WORM LYSIS profile (Table 3). The region flanking the CECL 
coding sequence was amplified by PCR before digestion by BsaAI and gel 
electrophoresis. 
Table 3: Thermal cycler condition used to lyse worms:  WORM LYSIS PCR Profile 
 
Temperature (˚C) Time Repeats 
55° 90 minutes  
95° 15 minutes  
 
C. elegans RNAi by feeding 
Generation of C. elegans males was typically carried out using RNAi. First, a 
starter culture of E. coli strain HT115 cells (an RNase III deficient derivative of the 
Berkley ‘B’ strain) that contained pGC363 (him-5 cloned into L4440 vector, obtained from 
the Caenorhabditis Genetics Center) was grown in 3 mL LB with 100 µg/mL ampicillin 
and 10 µg/mL tetracycline for 16 hours. Next, 1 mL of the starter culture was added to 9 
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mL of fresh LB that included ampicillin and tetracycline grown to OD600 0.5-0.8. 
Expression of double-stranded RNA (dsRNA) was induced by the addition of IPTG to a 
concentration of 0.4 µL and shaken at 37°C for 4 hours. Bacteria were spread on solid 
NGM media, containing 100 µg/mL ampicillin and 10µg/mL tetracycline and 1 µM IPTG 
and allowed to dry. Plates with bacteria expressing dsRNA must be used fresh. Six L4 
stage animals were then transferred to the lawn to consume the bacteria and lay eggs. 
Three days later, males were selected visually from the plate and passaged regularly in 
order to maintain a supply of males.  
 
Genetic Crossing of C. elegans 
Crossing of C. elegans strains was accomplished by crossing a mutant 
hermaphrodite with wild-type (N2) males. An NGM plate seeded with a drop of OP-50 
was allowed to dry overnight. A small lawn forces interaction between the males and 
hermaphrodites, as the animals do not tend to exit a food source. Six adult N2 males 
were then transferred to the lawn. A single worm in the L4 stage was added and the 
plate allowed to incubate at 20°C for two days. A successful cross would be expected to 
yield half males. Heterozygous hermaphrodites are selected and can be again 
outcrossed or allowed to reproduce independently to create homozygotes for future 
experiments. 
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Table 4: Primers used for C. elegans cloning, vectors with universal ends 
 
 
 
Universal end vectors  
Primer Name Primer Sequence                  5’-3’ direction 
pET14b	Univ	
Ends	FWD	
GAT	CCG	GCT	GCT	AAC	AAA	GCC	CG	
 
pET14b	Univ	
Ends	Rev	
CAT	ATG	GCT	GCC	GCG	CGG	CAC	CAG	GCC	GCT	GC	
 
pET42a	vect	
rev	
GAT	TTT	GAC	CAA	TGT	TTC	TCC	AGC	ATG	ACC	CGC	GTC	CCT	CAA	TA	
 
pET42a	vect	
fwd	
GAA	AGA	GGA	AGA	AAG	AAA	AGA	AGA	TTG	TGA	ATA	AGT	GAG	GCC	
GCA	CTC	GAG	C	
pEGFP-C1		univ	
FWD	
GGA	TCC	ACC	GGA	TCT	AGA	TAA	CTG	ATC	ATA	ATC	AGC	
 
pEGFP-C1	univ	
FWD	
CGA	AGC	TTG	AGC	TCG	AGA	TCT	GAG	TC	
 
pT7CFE1	univ	
ends	FWD	
CTC	GAG	CAC	CAC	CAC	CAC	
 
pT7CFE1	univ	
ends	REV	
GTG	GTG	GTG	GTG	CTC	GAG	
 
L3786	vect	
FWD	
GAG	GAA	GAA	AGA	AAA	GAA	GAT	TGT	GAA	TAA	GCG	GCC	GCT	GTA	
CAC	C	
L3786	vect	REV	 CTG	AAT	GGT	ACC	CCA	TCG	TAA	CAT	TTT	TCT	AGA	ACC	CGG	GTT	CGT	
AC	
L3704	vect	Ct	
GFP	FWD	
GTA	CCG	GTA	GAA	AAA	ATG	AGT	AAA	GGA	GAA	GAA	CTT	TTC	ACT	GG	
 
L3704	vect	Ct	
GFP	REV	
GGG	ATC	CTC	TAG	CCG	ATG	CCT	TTA	TTT	TTA	CTG	AAA	ATT	AAA	TAC	
 
L3786	N-term	
GFP	unit	ends	
FWD	
GAA	TTC	GCT	AGC	CGG	CCA	TAC	AAG	
 
L3786	N-term	
GFP	univ	ends	
REV	
CTT	GTA	TGG	CCG	GCT	AGC	GAA	TTC	
 
L5494	ctgfp	
vect	FWD	
CTG	TAC	ACC	CGG	GTA	CCG	GTA	GAA	AAA	ATG	AG	
 
L5494	ctgfp	
vect	REV	
AGG	ATC	CTC	AGC	TAT	CTT	GGT	TTT	TGC	TCG	
 
L5767	ctgfp	
vect	FWD	
GTC	GTA	TTG	GTA	CCG	GTA	GAA	AAA	ATG	AGT	AAA	GGA	GAA	GAA	CTT	
TTC	
L5767	ctgfp	
vect	REV	
GGC	CGC	GAA	TCG	ATA	GGA	TCC	TCT	AGA	
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Table 5: Primers used for C. elegans cloning into vectors with universal ends 
Cloning Insert Primers 
Primer name Primer Sequence                  5’-3’ direction 
L2	CP1	42b	
FWD	
CAG	GCC	TTG	GCG	CGC	CTG	CAG	GCG	AGC	TCC	TGG	ATT	GGC	AAA	TGT	
GAT	GTG	TAT	CGT	TTT	ATG	C	
L2	CP1	42b	REV	
sequence	
GTG	GTG	GTG	GTG	GTG	GTG	GTG	GTG	CTC	GAG	TCA	CCA	ATC	GGT	
CAG	GGT	ACG	G	
Syn	E2	42b	
FWD	
ACA	GGC	CTT	GGC	GCG	CCT	GCA	GGC	GAG	CTC	CAT	GCT	GGA	AAA	ACA	
TTG	GAG	CAA	AAG	CC	
Syn	E8	42b	REV	
 
GTG	GTG	GTG	GTG	GTG	GTG	GTG	GTG	CTC	GAG	TCA	ACC	TTT	GCG	
GGA	AAT	ATA	GCT	GCT	G 
L2	pET14b	ins	
FWD	
AGC	AGC	GGC	CTG	GTG	CCG	CGC	GGC	AGC	CAT	ATG	ATG	CTG	CGT	
TGG	GGC	ACC	ATT	CAG	CAG	
L2	pET14b	ins	
REV	
CGG	GCT	TTG	TTA	GCA	GCC	GGA	TCT	TTG	TTA	ACG	ATT	TTT	TTC	TCT	
TTT	TTA	CGT	TTA	CCG	CCT	TTT	TTA	CCG	ATT	TCC	
Syn	E2	14b	
FWD	
GCA	GCG	GCC	TGG	TGC	CGC	GCG	GCA	GCC	ATA	TGA	TGC	TGG	AAA	
AAC	ATT	GGA	GCA	AAA	GCC	
Syn	E8	14b	REV	 CGG	GCT	TTG	TTA	GCA	GCC	GGA	TCT	CAA	CCT	TTG	CGG	GAA	ATA	TAG	
CTG	CTG 
Ce	L2	pET42b	
FWD	
CGC	CTG	CAG	GCG	AGC	TCA	TGT	TAC	GAT	GGG	GTA	CCA	TTC	AGC	AGA	
TC	
Ce	L2	pET42b	
REV	
GTG	GTG	GTG	GTG	GTG	CTC	GAG	TCA	CTT	ATT	CAC	AAT	CTT	CTT	TTC	
TTT	CTT	CCT	CTT	TCC	ACC	TTT	C	
Ce	L2	pET14b	
FWD	
AGC	AGC	GGC	CTG	GTG	CCG	CGC	GGC	AGC	CAT	ATG	ATG	TTA	CGA	
TGG	GGT	ACC	ATT	CAG	CAG	ATC	
Ce	L2	pET14b	
REV	
CGG	GCT	TTG	TTA	GCA	GCC	GGA	TCT	CAC	TTA	TTC	ACA	ATC	TTC	TTT	
TCT	TTC	TTC	CTC	TTT	CCA	CCT	TTC	
UNEL	42b	stp	
FWD	
GCT	AAC	GTC	CCA	GAA	AAC	TAG	CTC	GAG	CAC	CAC	CAC	CAC	
 
UNEL	42b	STP	
REV	
GTG	GTG	GTG	GTG	CTC	GAG	CTA	GTT	TTC	TGG	GAC	GTT	AGC	
Co	CECL	42b	
FWD	
CAG	GCC	TTG	GCG	CGC	CTG	CAG	GCG	AGC	TCC	GGT	TTT	CAT	GTT	ACC	
CTG	AGC	TGT	AGC	CTG 
Co	CECL	42b	
REV	
GTG	GTG	GTG	GTG	GTG	GTG	GTG	GTG	CTC	GAG	TCA	TTT	GTT	AAC	GAT	
TTT	TTT	CTC	TTT	TTT	ACG	TTT	ACC	GCC	
CECL	42b	fwd	
 
CAG	GCC	TTG	GCG	CGC	CTG	CAG	GCG	AGC	TCC	TTT	CAT	GTT	ACC	CTG	
AGC	TGT	AGC	CTG	G	
CECL42b	REV	
 
GTG	GTG	GTG	GTG	GTG	GTG	GTG	GTG	CTC	GAG	TTA	TTT	GTT	AAC	GAT	
TTT	TTT	CTC	TTT	TTT	ACG	TTT	ACC	GCC	TTT	TTT	ACC	G	
CECL	in	pET14b	
Forward	
CCG	CGC	GGC	AGC	CAT	ATG	GTT	TCC	ACG	TAA	CTC	TAT	CGT	GTA	GCT	
TGG	AAG	G	
CECL	in	pET14b	
Reverse	
CTC	GAG	GAT	CCG	GCT	GCT	AAC	AAA	GTC	ACT	TAT	TCA	CAA	TCT	TCT	
TTT	CTT	TCT	TCC	TCT	TTC	CAC	C	
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Syn	LARS-2	
FWD	
ATG	CTG	CGT	TGG	GGC	
 
Syn	LARS-2	REV	 TTA	TTT	GTT	AAC	GAT	TTT	TTT	CTC	TTT	TTT	AC	
L2	delta	E9	
pT7CFE1	REV	
GTG	GTG	GTG	GTG	CTC	GAG	TCA	CTT	ATT	CAC	AAT	CTT	CTT	TTC	TTT	
CTT	CCT	CTT	TCC	ACC	TTT	CTT	CC	
SynL2	pT7CFE1	
FWD	
ATG	GCC	ACC	ACC	CAT	ATG	ATG	CTG	CGT	TGG	GGC	ACC	
 
SynL2	pT7CFE1	
REV	
GTG	GTG	GTG	GTG	CTC	GAG	TTT	GTT	AAC	GAT	TTT	TTT	CTC	TTT	TTT	
ACG	TTT	ACC	GCC	TTT	TTT	ACC	G	
CeL2	pT7CFE1	
FWD	
ATG	GCC	ACC	ACC	CAT	ATG	ATG	TTA	CGA	TGG	GGT	ACC	ATT	CAG	CAG	
ATC	
CeL2	pT7CFE1	
REV	
CTT	ATT	CAC	AAT	CTT	CTT	TTC	TTT	CTT	CCT	CTT	TCC	ACC	TTT	CTT	CCT	
TAT	TCA	CAA	TCT	TCT	TTT	CTT	TCT	TCC	TCT	TTC	CAC	CTT	TC	
UNE-L	p14b	
FWD	
CCG	CGC	GGC	AGC	CAT	ATG	CCG	AAA	TTC	GAA	GTG	AGC	CTC	TGG	AGA	
TAC	
UNE-L	p14b	
REV	
CTT	TGT	TAG	CAG	CCG	GAT	CCT	CGA	GGT	TTT	CTG	GGA	CGT	TAG	CCT	
TGT	ACA	CAA	TAG	TAC	
UNE-L	p42b	
FWD	
CGC	CTG	CAG	GCG	AGC	TCC	CGA	AAT	TCG	AAG	TGA	GCC	TCT	GGA	GAT	
AC	
UNE-L	p42b	
REV	
GTG	GTG	GTG	GTG	GTG	CTC	GAG	GTT	TTC	TGG	GAC	GTT	AGC	CTT	GTA	
CAC	AAT	AGT	AC	
UNE-L	IVT	FWD	
 
ATG	GCC	ACC	ACC	CAT	ATG	CCG	AAA	TTC	GAA	GTG	AGC	CTC	TGG	AGA	
TAC	
UNE-L	IVT	REV	
 
GTG	GTG	GTG	GTG	CTC	GAG	GTT	TTC	TGG	GAC	GTT	AGC	CTT	GTA	CAC	
AAT	AGT	AC	
L2	L3704	ins	
ctgfp	FWD	
GTA	TTT	AAT	TTT	CAG	TAA	AAA	TAA	AGG	CAT	CGG	CTA	GAG	GAT	CCC	
ATG	TTA	CGA	TGG	GGT	ACC	ATT	CAG	CAG	ATC	C	
L2	L3704	ins	
ctgfp	REV	
CCA	GTG	AAA	AGT	TCT	TCT	CCT	TTA	CTC	ATT	TTT	TCT	ACC	GGT	ACC	
TTA	TTC	ACA	ATC	TTC	TTT	TCT	TTC	TTC	CTC	TTT	CCA	CCT	TTC	TTC	CC	
GFP::CECL	FWD	
 
CTT	TGG	AAT	TCG	CTA	GCC	GGC	CAT	ACA	AGT	TCC	ACG	TAA	CTC	TAT	
CGT	GTA	GCT	TGG	AAG	
GFP::CECL	REV	 CAA	CGA	CGT	TGG	CGT	CGA	TCA	TCC	GGA	TTA	TCA	CTT	ATT	CAC	AAT	
CTT	CTT	TTC	TTT	CTT	CCT	CTT	TCC	ACC	
L2	deltaCECL	
ins	ctGFP	FWD	
GTA	TTT	AAT	TTT	CAG	TAA	AAA	TAA	AGG	CAT	CGG	CTA	GAG	GAT	CCC	
TTC	CAC	GTA	ACT	CTA	TCG	TGT	AGC	TTG	GAA	GGT	G	
L2	deltaCECL	
ins	ctGFP	REV	
GAA	AAG	TTC	TTC	TCC	TTT	ACT	CAT	TTT	TTC	TAC	CGG	TAC	ACC	TTT	
CCT	AGA	AAT	ATA	ACT	TGA	ATT	TTT	CAG	CTT	CAT	TCC	ATC	TTC	TTT	
CAT	CAT	TCG	
Exon9	L3786	
FWD	
GCC	GTA	CGA	ACC	CGG	GTT	CTA	GAG	GTT	TCC	ACG	TAA	CTC	TAT	CGT	
GTA	GCT	TGG	
Exon	9	L3786	
REV	
GCG	GCC	GCT	GTA	CAC	CCT	CAC	TTA	TTC	ACA	ATC	TTC	TTT	TCT	TTC	
TTC	CTC	TTT	CC	
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GFP::CECL	ins	
L3786	FWD	
GGA	ATT	CGC	TAG	CCG	GCC	ATA	CAA	GAT	GGT	TTC	CAC	GTA	ACT	CTA	
TCG	TGT	AGC	TTG	GAA	G	
GFP::CECL	ins	
L3786	REV	
ACG	TTG	GCG	TCG	ATC	ATC	CGG	ATT	ATC	ACT	TAT	TCA	CAA	TCT	TCT	
TTT	CTT	TCT	TCC	TCT	TTC	CAC	CTT	TC	
GFP::UNEL	ins	
L3786	FWD	
GGA	ATT	CGC	TAG	CCG	GCC	ATA	CAA	GCC	GAA	ATT	CGA	AGT	GAG	CCT	
CTG	GAG	ATA	C	
GFP::	UNEL	ins	
L3786	REV	
UNE-L	L3786	
FWD	
ACG	TTG	GCG	TCG	ATC	ATC	CGG	ATT	ATC	ACT	TAT	TCA	CAA	TCT	TCT	
TTT	CTT	TCT	TCC	TCT	TTC	CAC	CTT	TC	
GCC	GTA	CGA	ACC	CGG	GTT	CTA	GAC	CGA	AAT	TCG	AAG	TGA	GCC	TCT	
GGA	GAT	AC	
UNE-L	L3786	
REV	
GGG	TGT	ACA	GCG	GCC	GCG	TTT	TCT	GGG	ACG	TTA	GCC	TTG	TAC	ACA	
ATA	GTA	C	
L2	L5494	ins	
ctgfp	FWD	
CGA	GCA	AAA	ACC	AAG	ATA	GCT	GAG	GAT	CCT	ATG	TTA	CGA	TGG	GGT	
ACC	ATT	CAG	CAG	ATC	C	
L2	L5494	ins	
ctgfp	REV	
CTC	ATT	TTT	TCT	ACC	GGT	ACC	CGG	GTG	TAC	AGC	TTA	TTC	ACA	ATC	
TTC	TTT	TCT	TTC	TTC	CTC	TTT	CCA	CCT	TTC	TTC	CC	
L2	deltacecl	
L5494	ins	ctgfp	
REV	
CTC	ATT	TTT	TCT	ACC	GGT	ACC	CGG	GTG	TAC	AGA	CCT	TTC	CTA	GAA	
ATA	TAA	CTT	GAA	TTT	TTC	AGC	TTC	ATT	CCA	TCT	TCT	TTC	ATC	ATT	CG	
 
CECL	L5494	ins	
ctgfp	FWD	
CGA	GCA	AAA	ACC	AAG	ATA	GCT	GAG	GAT	CCT	TTC	CAC	GTA	ACT	CTA	
TCG	TGT	AGC	TTG	GAA	GGT	G	
L2	L5767	ctgfp	
ins	FWD	
TCT	AGA	GGA	TCC	TAT	CGA	TTC	GCG	GCC	ATG	TTA	CGA	TGG	GGT	ACC	
ATT	CAG	CAG	ATC	C	
L2	L5767	ctgfp	
ins	REV	
 
GAA	AAG	TTC	TTC	TCC	TTT	ACT	CAT	TTT	TTC	TAC	CGG	TAC	CAA	TAC	
GAC	CTT	ATT	CAC	AAT	CTT	CTT	TTC	TTT	CTT	CCT	CTT	TCC	ACC	TTT	CTT	
CCC	
L2	L5676	
deltaCECL	
ctgfp	ins	REV	
GAA	AAG	TTC	TTC	TCC	TTT	ACT	CAT	TTT	TTC	TAC	CGG	TAC	CAA	TAC	
GAC	CAC	CTT	CCA	AGC	TAC	ACG	ATA	GAG	TTA	CGT	GGA	A	
 
CECL	L5767	
ctGFP	ins	FWD	
TCT	AGA	GGA	TCC	TAT	CGA	TTC	GCG	GCC	TTC	CAC	GTA	ACT	CTA	TCG	
TGT	AGC	TTG	GAA	GGT	G	
CECL	
mammalian	ins	
fwd	
CCG	CCG	CCG	GGA	TCA	CTC	
	
CECL	
Mammalian	
ins	REV	
GGG	AGG	TTT	TTT	AAA	GCA	AGT	AAA	ACC	TCT	ACA	AAT	GTG	GTA	TGG	
	
Promoter	FWD	 CCA	TGG	CTT	CGA	TGC	CTT	CGT	C	
Promoter	REV	
for	linear	GFP	
ACC	TTT	CCT	AGA	AAT	ATA	ACT	TGA	ATT	TTT	CAG	CTT	CAT	TCC	ATC	
TTC	TTT	CAT	CAT	TCG	
GFP	FWD	
	
GAA	GAT	GGA	ATG	AAG	CTG	AAA	AAT	TCA	AGT	TAT	ATT	TCT	AGG	AAA	
GGT	GTC	GTA	TTG	GTA	CCG	GTA	GAA	AAA	ATG	AGT	AAA	GGA	G	
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GFP	REV	
	
CAA	GCT	ACA	CGA	TAG	AGT	TAC	GTG	GAA	ACC	CTT	GTA	TGG	CCG	GCT	
AGC	GAA	TTC	
CECL	3	FWD	
	
GAA	TTC	GCT	AGC	CGG	CCA	TAC	AAG	GGT	TTC	CAC	GTA	ACT	CTA	TCG	
TGT	AGC	TTG	
CECL	3	REV	 GAA	CGC	GAA	TTG	CGT	TTC	GTC	C	
L2	3786	FWD	-	
XbaI	
GTA	CCG	CTA	GCC	GTA	CGA	ACC	CGG	GTT	CTA	GAA	TGT	TAC	GAT	GGG	
GTA	CCA	TTC	AGC	
Exon	1	Rev	
	
GAA	TAT	ATT	TCT	TTC	CAT	TGA	GAT	TGC	TGG	GTT	TAT	TTT	TTG	AAG	
ATT	CAA	AAG	AAT	CGA	CAA	G	
Exon	2	FWD	
	
CTT	GTC	GAT	TCT	TTT	GAA	TCT	TCA	AAA	AAT	AAA	CCC	AGC	AAT	CTC	
AAT	GGA	AAG	AAA	TAT	ATT	C	
Exon	2	Rev	
	
CTC	CGT	TCA	AAA	CTT	GAA	ACG	GAA	GTT	TGT	ATG	GAA	ACT	GCG	TGG	
CAT	CCT	TGT	CTG	CCA	ACG	
Exon	3	Fwd	
	
CGT	TGG	CAG	ACA	AGG	ATG	CCA	CGC	AGT	TTC	CAT	ACA	AAC	TTC	CGT	
TTC	AAG	TTT	TGA	ACG	GAG	
Exon	3	Rev	
 
CGG	GAT	GTT	TCA	TAG	CCA	CCG	TAT	CCA	CCA	AAC	GAT	GCC	ATC	TCC	
TGA	ATA	TCA	TTC	TTC	GTC	
Exon	4	Fwd	
 
GAC	GAA	GAA	TGA	TAT	TCA	GGA	GAT	GGC	ATC	GTT	TGG	TGG	ATA	
CGG	TGG	CTA	TGA	AAC	ATC	CCG	
Exon	4	Rev	
 
CGC	TTT	TAT	TTT	TGT	TGT	CAA	GGT	ATC	GAA	GAT	AGT	ACC	ATG	CAG	
AAT	CAA	AGA	ATG	TAT	CAA	GAG	TAT	CTG	TGT	CG	
Exon	5	Fwd	
 
CGA	CAC	AGA	TAC	TCT	TGA	TAC	ATT	CTT	TGA	TTC	TGC	ATG	GTA	CTA	
TCT	TCG	ATA	CCT	TGA	CAA	CAA	AAA	TAA	AAG	CG	
Exon	5	Rev	
 
GTG	GGA	TGA	GGT	CAG	TGA	ATG	GTT	CAG	CTG	TCT	GGA	TAA	CAT	TGA	
TAT	CCT	TCA	AGA	AAT	ATG	C	
Exon	6	Fwd	
 
GCA	TAT	TTC	TTG	AAG	GAT	ATC	AAT	GTT	ATC	CAG	ACA	GCT	GAA	CCA	
TTC	ACT	GAC	CTC	ATC	CCA	C	
Exon	6	Rev	
 
GGG	CTG	TGA	GCC	AGG	TAG	ATT	GGA	TCA	ACT	TTC	TTT	AAT	GCA	TTA	
GTG	AAT	CCC	TGT	ATT	CTC	ATC	
Exon	7	Fwd	
 
GAT	GAG	AAT	ACA	GGG	ATT	CAC	TAA	TGC	ATT	AAA	GAA	AGT	TGA	TCC	
AAT	CTA	CCT	GGC	TCA	CAG	CCC	
Exon	7	Rev	
 
CCA	CAT	TTC	GGA	AGC	GAC	GTG	TGG	ACA	AAA	AAC	TTG	AAG	CAT	AAT	
AAT	CAA	CGA	TTT	CAC	CGC	
Exon	8	Fwd	 GCG	GTG	AAA	TCG	TTG	ATT	ATT	ATG	CTT	CAA	GTT	TTT	TGT	CCA	CAC	
GTC	GCT	TCC	GAA	ATG	TGG	
FL	L2	L3786	
delta	exon	9	
Rev	
TAT	AGG	GCA	CCC	GGG	TGT	ACA	GCG	GCC	GCC	TTT	CCT	AGA	AAT	ATA	
ACT	TGA	ATT	TTT	CAG	CTT	CAT	TCC	ATC	
 
Exon	9	Fwd	 GGA	ATG	AAG	CTG	AAA	AAT	TCA	AGT	TAT	ATT	TCT	AGG	AAA	GGT	TTC	
CAC	GTA	ACT	CTA	TCG	TGT	AGC	TTG	G	
L2	3786	REV	Ð	
NotI	
TAT	AGG	GCA	CCC	GGG	TGT	ACA	GCG	GCC	GCC	TTA	TTC	ACA	ATC	TTC	
TTT	TCT	TTC	TTC	CTC	
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Table 5 (cont.) 
 
Table 6: Primers used for sequencing C. elegans plasmid constructs 
 
tRNA1	 AGC	TTT	AAT	ACG	ACT	CAC	TAT	A	
tRNA2	 GTT	GAT	ATA	GCA	TAA	GAA	
tRNA3	 GTG	CAT	TTG	TTT	TAA	GCG	
tRNA4	 CAA	AAG	ATA	TCC	GTC	AAC	TG	
tRNA5	 ATC	AAC	TAT	AGT	GAG	TCG	TAT	TAA	
tRNA6	 AAA	TGC	ACT	TCT	TAT	GCT	AT	
tRNA7	 ATC	TTT	TGC	GCT	TAA	AAC	
tRNA8	 ATC	CAG	TTG	ACG	GAT	
Sequencing Primers 
Primer Name Primer Sequence          5’-3’ direction 
CEF	1	 ATG	TTA	CGA	TGG	GGT	ACC	ATT	CAG	CAG	ATC	
CEF	500	 ACT	TTT	TGA	GTA	CGG	ACT	GGT	GAA	ACG	AAC	ATC	
CEF	1000	 TCA	CAA	GCT	TCT	TGA	ACT	CGA	GAA	TTG	GAA	ACT	TTC	
CEF	1500	 TTT	GTT	GCA	TAT	TTC	TTG	AAG	GAT	ATC	AAT	GTT	ATC	CAG	ACA	G	
CEF	2000	 ACT	TCA	TCT	TCA	TAA	TAC	TGC	GTT	GAT	GAG	AAT	ACA	GG	
CEF	2500	 GAA	TTC	AAG	CAG	AGA	AGA	GAA	AGT	TGG	AAA	TCG	G	
CER	250 AGA	TTG	TAT	AAA	CTC	TCA	TAT	GGC	CAA	TAT	GAA	GTC	GTC	C	
CER	750	 GAT	CCA	ATT	AGC	TTG	AAT	ATC	AGC	AAC	TTC	TCC	C	
CER	1250	 ACA	GCA	ACT	CGT	TTT	CCG	TCT	TTG	G	
CER	1750	 AAA	TTG	CAG	CCA	AAT	CTA	CGC	CGT	TG	
CER	2250	 CAG	AAG	AAA	TTC	AAT	ATC	AGC	ATC	TTT	ATC	AAC	TTC	GGG	
SynL2F	1	 ACT	AGT	ATG	CTG	CGT	TGG	GGC	
SynL2F	500	 GCA	AAC	TGT	TTG	AAT	ATG	GTC	TGG	
SynL2F	1000	 CCT	ATC	AGC	CGG	ATG	TTA	CCA	GC	
SynL2F	1500	 GCA	CGT	TTT	GTT	GCC	TAT	TTT	CTG	
SynL2F	2000	 GTG	CGC	AAT	GTT	GGT	ATG	TGT	CTG	G	
SynL2F	2500	 CTG	GAT	CGC	ATT	CAG	GCC	G	
SynL2R	250	 CGT	GCG	GTT	GCA	TCA	CTA	ATG	
SynL2R	750	 CAC	ATT	TGC	CAA	TCC	AAT	TTG	CCT	G	
SynL2R	1250	 GCA	CTG	CAA	CAC	GTT	TGC	CAT	C	
SynL2R	1750	 CGC	TAT	CCA	GAA	TGG	CTG	CCA	G	
SynL2R	2250	 CCG	CTA	ACA	CCA	TCA	ATC	ATC	AG	
Nt	GFP	
external	primer	
REV	
GAA	TAC	GAA	TTG	GGA	GAC	GG	
 
GFP	FWD	
L3786	GFP	REV	
GGT	CCT	TCT	TGA	GTT	TGT	AAC	CAG	AAA	GTA	GTG	ACA	AGT	GTT	GG	
L3786	PreMCS	
FWD	
GCT	CAA	CAG	CGT	ACC	TAC	GAG	
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pEGFP-C1	5'	
sequencing	
CAT	GGT	CCT	GCT	GGA	GTT	CGT	G	
 
pEGFP-C1	
3'sequencing	
GAA	ATT	TGT	GAT	GCT	ATT	GC	
 
CECL	375F	 CAC	ACG	TCG	CTT	CCG	AAA	TGT	GG	
CECL	131	R	 CCT	CTT	TCC	ACC	TTT	CTT	CCC	GAT	TTC	CAA	C	
CetRNAUUR	
fwd	
AGC	TTT	AAT	ACG	ACT	CAC	TAT	AGT	TGA	TAT	AGC	ATA	AGA	AGT	GCA	
TTT	GTT	TTA	AGC	GCA	AAA	GAT	ATC	CGT	CAA	CTC	CAG	
CetRNAUUR	
rev	
GAT	CCT	GGT	GTT	GAC	GGA	TAT	CTT	TTG	CGC	TTA	AAA	CAA	ATG	CAC	
TTC	TTA	TGC	TAT	ATC	AAC	TAT	AGT	GAG	TCG	TAT	TAA	
ColE1	FWD	 GTT	CGT	GCA	CAC	AGC	CCA	GCT	TG	
ColE1	REV	 CAA	GCT	GGG	CTG	TGT	GCA	CGA	AC	
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Results  
 
Identification of a unique C-terminus of Caenorhabditis mitochondrial LeuRS 
 The mitochondrial LeuRS (mtLeuRS) gene of C. elegans is encoded on 
chromosome 1 of the C. elegans genome. This gene encodes the 859 amino acid 
mtLeuRS enzyme and contains all of the putative catalytic and structural motifs such as 
the Rossman-fold containing catalytic domain, the connective polypeptide 1 (CP1) 
editing domain, the anticodon binding domain, and the C-terminal domain which binds 
the corner of the tRNA molecule. Also present is a unique C-terminal addition known as 
the C-terminal extension of Caenorhabditis mtLeuRS, or CECL (Figure 1). Across the 
three domains of life, this extension is not found in any other organism outside of 
Caenorhabditis species. 
 
 
Figure 1: C. elegans mitochondrial LeuRS contains a unique C-terminal extension. 
Alignment of the C-terminus portions of several species across the three domains 
highlights this extra domain added to the end of C. elegans mitochondrial LeuRS. 
Identical residues are highlighted black. Similar residues are highlighted in grey. The 
mtLeuRS sequence of C. elegans is shown in red. H. sapiens=Homo sapiens, R. 
norvegicus=Rattus norvegicus, M. musculus=Mus musculus, X. laevis=Xenopus laevis, 
D. rerio=Danio rerio, B. subtilis=Bacillus subtilis, D. melanogaster=Drosophila 
melanogaster, C. elegans=Caenorhabditis elegans, N. crassa=Neurospora crassa, S. 
cerevisiae=Sacchromyces cerevisiae.  
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Since no crystal structure is available for the C. elegans mitochondrial LeuRS, I 
utilized its overlap in primary sequences with E. coli and T. thermophiles LeuRS 
throughout its canonical domains to model the protein structure (modeling procedure 
described in methods) (Figure 2). This model revealed a typical LeuRS structure 
throughout each of its canonical domains, including the central Rossmann fold core, CP1 
editing domain, so-called anticodon binding domain, and the C-terminal domain that 
binds the corner of tRNA. 
Since there are no similar sequences in the protein structure database, the C-
terminal extension could not be modeled based on BLAST results.  Because the model 
of C. elegans LeuRS reflects a canonical LeuRS, we hypothesized that the CECL 
domain is dispensable for aminoacylation. It is possible that its addition conferred a 
second function for the mitochondrial LeuRS in C. elegans. 
 
Figure 2: Modeled structure of the C. elegans mitochondrial LeuRS. The model 
shows a typical, fully formed LeuRS structure. The catalytic domain (green), CP1 domain 
(orange), anticodon binding domain (red), and C-terminal domain (cyan) show no 
irregularities and the structure is docked with the E. coli tRNALeu (blue). 
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CECL is conserved in Caenorhabditis species. 
Alignment of multiple nematode species shows that the CECL extension is 
restricted to Caenorhabditis species (Figure 3). Specifically, the CECL domain only is 
present in the Elegans group of the Caenorhabditis genus. These Caenorhabditis 
species are members of the Elegans group of the Caenorhabditis genus, and the CECL 
sequence is highly conserved among these species. 
 
Figure 3: CECL is restricted to and conserved in Caenorhabditis species. With the 
exception of a few point mutations, the CECL domain is nearly uniform across these 
Caenorhabditis species. Identical residues highlighted in black, similar residues 
highlighted in grey. P. pacificus=Pristionchus pacificus 
 
 
CECL contains several putative NLSs 
Significantly, characterization of the CECL extension determined that it’s primary 
sequence is very positively charged with a pKa of 11.7. Inspection of the sequence of C. 
elegans mitochondrial LeuRS revealed sequences that corresponded to putative bipartite 
and monopartite NLSs (Figure 4). Nuclear localization sequences one and two 
correspond to classical bipartite NLS structure of two basic residues, followed by a 9-12 
residue spacer, followed by three basic residues. The third and fourth localization 
sequences correspond to classical monopartite nuclear localization sequences, which 
follow the pattern of Lys, Arg/Lys, any residue, Arg/Lys. This led us to suspect that in 
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addition to aminoacylating tRNALeu in the mitochondria, the LeuRS may also play an 
additional biological role in the nucleus.  
 
Figure 4: C. elegans CECL domain contains four NLS sequences. Basic amino acid 
residues are highlighted in red.  
 
 
To generate a model of CECL extension isolated from the rest of the LeuRS, 
HHPred was used to isolate smaller parts of multiple crystal structures in order to make 
a larger model of CECL (described in methods) (Figure 5). The CECL extension model is 
comprised of a helix-loop-helix motif. Interestingly, this motif is is also consistent with 
structures that bind nucleic acids (Brennan & Matthews, 1989). 
 
 
Figure 5: Model of CECL domain. The model of the CECL domain resembles a helix-
turn-helix motif. The N-terminus (far right) appears to be a poly-linker before the start of 
the ordered structure and series of basic resides. 
 
 24 
 
An annotated splice-variant lacks the mitochondrial targeting sequence  
All nuclear-encoded mitochondrial genes are tagged with an N-terminal 
mitochondrial targeting sequence (MTS) that targets proteins for translocation to the 
mitochondria (Häusler, Stierhof, Blattner, & Clayton, 1997; Heijne, 1986; Shimoda-
Matsubayashi et al., 1996). Upon entering the mitochondria, the sequence is cleaved, 
followed by folding of the translocated protein so that it can fulfill its function. The C. 
elegans mitochondrial LeuRS has both an MTS and four putative nuclear localization 
sequences. If the LeuRS is also targeted to the nucleus, how does it overcome 
competing pressure to localize to the mitochondria? We have two hypotheses to answer 
this question. The mitochondrial LeuRS localization patterns could be governed by 
equilibrium. In this case, some of the protein pool is in the mitochondria, while the other 
fraction is targeted to the nucleus based on the relative strength of each localization 
sequence.  
An alternative hypothesis is that the cell uses alternative splicing to generate a 
separate LeuRS mRNA, which lacks the MTS. An annotated splice variant for the 
mitochondrial LeuRS has been deposited in the manually curated WormBase (Figure 6) 
(O. L. Griffith & Griffith, 2004). In this example, the first two exons are removed from the 
LeuRS and translation begins at the fourth exon. This results in the loss of the first 404 
amino acids at the N-terminus. The resulting C-terminal portion of the spliced protein 
product that lacks the MTS is comprised of 455 amino acids and retains all of the nucleic 
acid binding topology of the full-length enzyme. The deletion retains the second half of 
the Rossman-fold, as well as the anticodon binding domain, C-terminal domain, and 
CECL domain. The CP1 editing domain is deleted. The HIGH motif, which aids in the 
formation of the leucyl-adenylate, is also deleted.   
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Figure 6: A splice-variant of the mitochondrial LeuRS lacks the MTS found in the 
full-length LeuRS. Removal of the MTS (purple) would allow the splice variant (sv) to 
gain entry into the nucleus without competing with the localization pressures conferred 
by the MTS. The HIGH motif is removed with much of the catalytic domain (green), and 
the entire CP1 editing domain (orange). The splice variant retains part of the catalytic 
domain along with the anticodon binding domain (red), C-terminal domain (cyan), and 
CECL domain (yellow). 
 
 
Mutants lacking CECL are unable to reliably produce homozygous progeny 
 
To begin to identify the functional role of the LeuRS CECL extension, I 
constructed a series of deletion mutants (Figure 7). Each deletion mutant completely 
lacks the NLS sequences of interest. The first mutant ∆CECL, is simply missing every 
amino acid after the first glycine in the CECL sequence. A frameshift mutant, ∆CECL-FS 
contains a mutation which disrupts the reading frame after the third CECL residue, a 
histidine, which results in three extra amino acids not found in CECL before the stop 
codon. Lastly, the ∆CECL-ins mutant is an insertion/deletion mutant that has an insertion 
after the first glycine of ten amino acids not found in CECL before a stop codon.  
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Figure 7: Three ∆CECL mutants generated by genome editing. We obtained 
mutants with a simple deletion and up to ten added residues. 
 
 These strains were passaged over 200 times. Homozygotes were observed 
twice for CECL-ins and once for CECL-sv. No visual phenotype was readily observed. 
Unfortunately, these worms did not lay eggs, so the strains could not be maintained as 
homozygotes. Furthermore, the strains were not able to survive being frozen as 
heterozygotes, as both our frozen stocks and the frozen stocks from Knudra did not have 
any surviving heterozygotes. This may be an attributable phenotype of the ∆CECL 
mutation. Freezing stocks of worms is common practice and although lethality tends to 
be high, stocks are frozen with such a large number of animals to guarantee rescue of a 
given allele.  Further testing on the phenotypes of these strains is necessary to better 
understand the functions of CECL. 
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Discussion   
While C. elegans is not widely used in the study of tRNA synthetases, it is an 
experimentally tractable genetic system worthy of being used to study these enzymes. 
The wide range of available techniques, fully-sequenced genome, and invariant cell-
lineage allow for ease of experimentation and observation not available in most 
multicellular systems. 
CECL is highly conserved in the Caenorhabditis species in which it is found. 
However, CECL is restricted to a very small clade of Caenorhabditis species (Figure 8). 
CECL is not found outside of Caenorhabditis. It is possible that CECL was appended to 
the LeuRS in the common ancestor of the subgroup of Caenorhabditis or alternatively, 
added much earlier and only retained by members of the Elegans subgroup. An 
understanding the evolutionary history of CECL will be very interesting when more is 
known about the CECL function. It will be interesting to see if this possible alternate 
function is retained in other eukaryotes but is carried out by other proteins. 
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Figure 8: CECL is restricted to a particular clade, known as the “Elegans group.” 
Other nematode species completely lack the CECL domain.  
 
Deletion of CECL coding sequence from the chromosome resulted in three sterile 
∆CECL homozygotes. Whatever role CECL may be playing thus appears essential for 
some aspect of worm development or survival. We did not observe unhatched eggs on 
mutant worm plates, nor were we able to identify homozygous ∆CECL larval animals. 
Further, we were unable to observe unfertilized eggs on any of the plates. We surmise 
this means that ∆CECL homozygotes are not created due to some deficiency in the 
gametes or fertilization.  
The Caenorhabditis mitochondrial LeuRSs contain a unique, highly alkali 
extension that is added to the C-terminus of the LeuRS enzyme. We anticipate that it is 
likely dispensable for aminoacylation, because the remainder of the full-length LeuRS 
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from the C. elegans mitochondria contains all canonical domains that are responsible for 
tRNA binding and aminoacylation.  
We hypothesize that the CECL domain targets either the full-length LeuRS or its 
splice variant that is missing 455 N-terminal residues to the nucleus. Its high pKa due to 
an enrichment of lysines and arginines corresponds to at least four putative NLS. As 
such., we expect that the mitochondrial LeuRS has a nuclear function. Because the 
nucleic acid binding capacity of the LeuRS splice variant would be retained, it is possible 
that CECL directs it to the nucleus, where LeuRS can interact with nucleic acids, or 
perhaps a protein partner. If the splice-variant is the active molecule in this alternate 
function, it would also mean that the alternate function is distinct from tRNA 
aminoacylation. 
The splice-variant lacks the N-terminal mitochondrial targeting sequence, which 
would eliminate competition between the two competing localization sequences. The 
high pKa of the CECL domain and the putative NLSs contained within CECL indicate 
possible nuclear localization. High pKa values can also indicated nucleic acid binding 
ability. The model of CECL shows a helix-turn-helix motif, which can be characteristic of 
an NLS or nucleic acid binding motif. 
The model generated of full-length LeuRS lacks CECL yet retains each of the 
canonical domains of a fully-formed LeuRS. We believe that CECL is dispensable for 
aminoacylation. CECL is encoded on its own exon and alignments for the C-terminal 
portions of different LeuRSs show that CECL domain is an added appendage.  
Future ChIP experiments using full-length LeuRS, full-length ∆CECL, splice-
variant, splice-variant ∆CECL and CECL would provide great insight into the DNA 
binding abilities of the mitochondrial LeuRS as well as hints to what part of the LeuRS 
has activity in the nucleus, if any. Western blot analysis following cellular 
 30 
subfractionation will also be able to show that the mtLeuRS can be found outside the 
mitochondria and whether the mtLeuRS interacts with any protein partners 
Further microscopy studies should be carried out to look for morphologic 
abnormalities of the gonads or gametes. This may be able to explain why homozygotes 
are so rare. It can also explain what developmental defect prevents homozygotes from 
producing progeny.  
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Chapter 2 
Enzyme-RNA Interactions Between E. coli LeuRS and its tRNA Substrate 
 
Introduction 
 
Aminoacyl-tRNA synthetases carry out the two-step reaction of covalently linking 
an amino acid to its cognate tRNA.(Mascarenhas, An, Rosen, Martinis, & Musier-
Forsyth, 2009) In the first step of the reaction, ATP and an amino acid react to form an 
aminoacyl-adenylate. This adenylate is then transferred to the 3’ end of the tRNA, 
releasing AMP. Leucyl-tRNA synthetase (LeuRS) covalently links the amino acid leucine 
to tRNALeu before transferring the 3’ end of the aminoacylated tRNA to the connective 
peptide 1 (CP1) hydrolytic editing domain where mischarged amino acids are removed 
from the tRNA (Lin, Hale, & Schimmel, 1996; Richard S Mursinna, Tommie L Lincecum, 
& Martinis, 2001). 
 LeuRS is a globular protein comprised of several domains. The catalytic domain 
is composed of a Rossman nucleotide-binding fold interrupted by the CP1 editing 
domain insertion (Cusack, Yaremchuk, & Tukalo, 2000; Lin et al., 1996; Lincecum et al., 
2003). LeuRS, like other synthetases, has a C-terminal domain fused to the N-terminal 
core of the enzyme (Burbaum & Schimmel, 1991).Unlike other synthetases, LeuRS does 
not recognize the anticodon of the tRNA with its C-terminal domain (Asahara et al., 
1993; Larkin, Williams, Martinis, & Fox, 2002). Rather, an extension of the C-terminal 
domain of LeuRS is connected to the core by a flexible linker and contacts the corner of 
the L-shaped tRNA at the G19:C57 base pair (Palencia et al., 2012; Tukalo, Yaremchuk, 
Fukunaga, Yokoyama, & Cusack, 2005). Deletion of the LeuRS C-terminal domain 
greatly diminishes the aminoacylation and editing activities of E. coli LeuRS, indicating 
that the contact with the C-terminal domain is essential to both of these activities 
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(Fukunaga & Yokoyama, 2005; Hsu, Rho, Vannella, & Martinis, 2006; Tukalo et al., 
2005; Zheng et al., 2004). 
 In this study, we aim to find the critical interactions responsible for anchoring the 
E. coli tRNALeu to the E. coli LeuRS. Since our lab last investigated the C-terminal 
domain that binds the corner of tRNALeu, the full length E. coli LeuRS crystal structure 
bound to tRNALeu in the aminoacylation and editing complexes has been published 
(Palencia et al., 2012). Extensive network analysis based on this crystal structure has 
highlighted a triad of amino acid residues that contact the C19:C57 base pair at the 
“elbow” of the folded tRNA. Computational network analysis predicted strong interaction 
between the tRNA and each of these amino acids that were not mutated in the previous 
study (Eargle & Luthey-Schulten, 2012). We hypothesize that one or all of these three 
residues play an important role in stabilizing the tRNA on the enzyme during 
aminoacylation and editing reactions. 
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Methods 
 
Site Directed Mutagenesis 
Mutagenesis was done using the QuickChange strategy (Stratagene). The 
plasmid p15ec3-1, encoding the wild type E. coli LeuRS served as the template for all 
mutations. PCR reactions contained 0.2 ng/µL p15ec3-1, 500 nM forward and reverse 
primers, 200 µM each dNTP, commercial reaction buffer diluted to 1x, 2 mM MgCl2, 
0.025 U/µL GoTaq Green/Pfu DNA polymerases (Promega) or 0.02 U/µL KOD Xtreme 
(EMD Millipore) DNA polymerase. Thermal cycling conditions were carried out according 
TAQ STANDARD profile (See Table 1 in the previous chapter).  
 
In Vitro Transcription of tRNA 
The plasmid ptDNAleu14 that encodes E. coli tRNALeuUAA was purified with a 
Qiagen Mega Prep kit (Qiagen# 12183) and digested by BstNI (NEB# R0168) at 60°C 
for 6 hours. Agarose gel electrophoresis confirmed complete digestion of the plasmid. 
The digestion product was used for run-off in vitro transcription reaction containing 40 
mM Tris-HCl, pH 8.1, 80 mg/ml polyethylene glycol 8000, 5 mM dithiothreitol, 50 g/ml 
bovine serum albumin, 0.01% Triton X-100, 40 units of Prime RNase inhibitor 
(Eppendorf), 8 g/ml pyrophosphatase (Sigma-Aldrich), 5 mM spermidine, 7.5 mM ATP, 
7.5 mM CTP, 7.5 mM GTP, and 7.5 mM UTP, 60 g/ml template, 30 mM MgCl2, and 2 µM 
T7 RNA polymerase at 37°C. After four hours, NH4OAc was added to a concentration of 
2 M and the whole reaction was ethanol precipitated with 2 reaction volumes of 100% 
EtOH, centrifuged, washed twice with cold 70% EtOH, centrifuged again, and dried in a 
Savant Speed Vac.  
The dried tRNA was then resuspended in water. Reaction products were 
separated on a polyacrylamide gel containing 8 M urea. The appropriate size band of 87 
nucleotides was excised, crushed, and soaked in TBE buffer overnight. The 
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TBE/acrylamide mixture was placed in the sample chamber of an elutrap apparatus (GE 
Healthcare) filled with TBE. After electrophoresis for two hours at 200V, the TBE buffer 
containing pure tRNA was removed from the product chamber. NH4OAc was added to a 
concentration of 2 M and the solution was ethanol precipitated with 2 volumes of cold 
100% EtOH. The precipitation reactions were incubated at -80°C for 1 hour. Samples 
were centrifuged at 21k RCF for 30 minutes, washed with 70% cold EtOH and 
centrifuged again. The pellet was dried in a Speed Vac and resuspended in RNase free 
water. Total concentration was determined using a NanoDrop instrument. The tRNA 
product was heated to 80°C for 1 minute followed by addition of 1 mM MgCl2 and then 
quick-cooling on ice for 15 minutes to promote folding of the molecule..  
 
Aminoacylation assays 
Aminoacylation reactions (60 mM Tris-HCl, pH 7.5, 10 mM MgCl2,1mM 
dithiothreitol, 4 µM folded tRNALeu, 4 mM L-[14C]leucine (250 µCi/mL), 4 mM L-leucine, 
4mM ATP) were initiated with the addition of 50 µM E. coli LeuRS. Reaction time points 
were spotted on filter paper that had been presoaked with 5% trichloroacetic acid (TCA). 
The filter paper was washed three times with cold 5% TCA and once with cold 70% 
ethanol before being dried. Filter paper was placed in scintillation vile and submerged in 
scintillation fluid. Aminoacylated tRNA was quantitated using a Beckman LS6000IC 
scintillation counter.  
 
Protein induction and harvesting cells 
A colony of an E. coli expression strain containing the plasmid of interest was 
selected from solid media and used to inoculate a 3 mL overnight culture of LB with 
100µg/mL ampicillin. The starter culture was then used to inoculate a 1-4L flask of LB 
and grown to an OD600 of 0.5-1.0 before induction with 0.4µM IPTG. Induced cultures 
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were incubated 2 hours at 37˚C. Cells were harvested by centrifugation using a 
Beckman Avanti J-E.  
Ni-NTA protein purification   
 Protein purification for proteins tagged with a six histidine tag were purified as 
described in the previous chapter. 
Table 7: Primers used for site directed mutagenesis 
Primer Name Primer Sequence                  5’-3’ direction 
I848E FWD 
 
GGC GTT ACT GTA CGT AAA GTG GAG TAC GTA CCA GGT AAA 
CTC CTC 
I848E REV 
 
GAG GAG TTT ACC TGG TAC GTA CTC CAC TTT ACG TAC AGT 
AAC GCC  
I848F FWD 
 
GCG TTA CTG TAC GTA AAG TGT TCT ACG TAC CAG GTA AAC 
TCC  
I848F REV 
 
GGA GTT TAC CTG GTA CGT AGA ACA CTT TAC GTA CAG TAA 
CGC  
I848L FWD 
 
GCG TTA CTG TAC GTA AAG TGC TGT ACG TAC CAG GTA AAC 
TCC 
I848L REV 
 
GGA GTT TAC CTG GTA CGT ACA GCA CTT TAC GTA CAG TAA 
CGC  
I848N FWD 
 
GCG TTA CTG TAC GTA AAG TGA ACT ACG TAC CAG GTA AAC 
TCC TC 
I848N REV 
 
GAG GAG TTT ACC TGG TAC GTA GTT CAC TTT ACG TAC AGT 
AAC GC  
I848V FWD 
 
GGC GTT ACT GTA CGT AAA GTG GTC TAC GTA CCA GGT AAA 
CTC CTC 
I848V REV 
 
GAG GAG TTT ACC TGG TAC GTA GAC CAC TTT ACG TAC AGT 
AAC GCC  
L855E FWD CGT ACC AGG TAA ACT CGA AAA TCT GGT CGT TGG C 
L855E REV GCC AAC GAC CAG ATT TTC GAG TTT ACC TGG TAC G  
L855F FWD CGT ACC AGG TAA ACT CTT CAA TCT GGT CGT TGG C  
L855F REV GCC AAC GAC CAG ATT GAA GAG TTT ACC TGG TAC G  
L855I FWD CGT ACC AGG TAA ACT CAT CAA TCT GGT CGT TGG 
L855I REV CCA ACG ACC AGA TTG ATG AGT TTA CCT GGT ACG  
L855N FWD CGT ACC AGG TAA ACT CAA CAA TCT GGT CGT TGG C 
L855N REV GCC AAC GAC CAG ATT GTT GAG TTT ACC TGG TAC G  
L855V FWD CGT ACC AGG TAA ACT CGT CAA TCT GGT CGT TG 
L855V REV CAA CGA CCA GAT TGA CGA GTT TAC CTG GTA CG  
N856A FWD GTA CCA GGT AAA CTC CTC GCT CTG GTC GTT GGC TAA TAG 
N856A REV CTA TTA GCC AAC GAC CAG AGC GAG GAG TTT ACC TGG TAC 
N856D FWD 
 
CGT ACC AGG TAA ACT CCT CGA CCT GGT CGT TGG CTA ATA 
G 
N856D REV 
 
CTA TTA GCC AAC GAC CAG GTC GAG GAG TTT ACC TGG TAC 
G 
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Table 7 (cont.) 
N856L FWD 
 
CGT ACC AGG TAA ACT CCT CTT GCT GGT CGT TGG CTA ATA 
GG 
N856L REV 
 
CCT ATT AGC CAA CGA CCA GCA AGA GGA GTT TAC CTG GTA 
CG 
N856Q FWD 
 
CGT ACC AGG TAA ACT CCT CCA GCT GGT CGT TGG CTA ATA 
G 
N856Q REV 
 
CTA TTA GCC AAC GAC CAG CTG GAG GAG TTT ACC TGG TAC 
G 
N856R FWD GTA CCA GGT AAA CTC CTC AGA CTG GTC GTT GGC TAA TAG 
N856R REV CTA TTA GCC AAC GAC CAG TCT GAG GAG TTT ACC TGG TAC 
G19C FWD 
 
GCC CGG ATG GTG GAA TCG CTA GAC ACA AGG GAT TTA AAA 
TC 
G19C REV 
 
GAT TTT AAA TCC CTT GTG TCT AGC GAT TCC ACC ATC CGG 
GC 
C57G FWD 
 
CGC GCT GTG CGG GTT GAA GTC CCG CTC CGG GTA CCA 
GGC 
C57G REV 
 
GCC TGG TAC CCG GAG CGG GAC TTC AAC CCG CAC AGC 
GCG 
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Results 
 
C-terminal domain of E. coli LeuRS contacts the tRNA “elbow” 
The crystal structure for E. coli LeuRS (PDB: 4AQ7) was used to analyze the 
nature of the interactions between the tRNALeu molecule and the C-terminal domain that 
is uniquely appended to virtually all LeuRS enzymes. Based on this structure, Eargle and 
Luthey-Schulten performed a community analysis to identify nodes of strong interactions 
that might bridge long distance signaling pathways (Eargle & Luthey-Schulten, 2012). In 
particular, this computational investigation highlighted the highly conserved residue 
L855, and less conserved residues I848 N856 as critical interactions with the tRNA 
(Figure 9).   
 
Figure 9: Close-up view of the interaction between the E. coli LeuRS C-terminal 
domain and the elbow of the L-shaped tRNALeu. Community analysis highlighted 
three residues (shown in magenta) of the C-terminal domain (cyan) as being critical 
interacting partners with the tRNA (blue).  In the background, the catalytic domain is 
depicted in green, the anticodon binding domain in red, and the CP1 editing domain in 
orange. 
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Although isoleucine is not capable of any polar interactions with the tRNA, I848 
showed the most promise based on the computational network analysis. This residue 
was mutated to glutamic acid, phenylalanine, leucine, asparagine, and valine and tested 
for aminoacylation. None of the I848 mutants significantly affected aminoacylation 
(Figure 10). 
 
 
Figure 10: Mutational analysis of I848 shows no effects on aminoacylation. 
Aminoacylation reactions performed in triplicate. Maximum velocity of all mutants closely 
matches aminoacylation activity of wild-type.   
 
 
The residue L855 was also suggested via computational analysis to be an 
important interaction with the tRNA. I mutated L855 to alanine, glutamic acid, 
phenylalanine, isoleucine, arginine, and valine to test whether this residue contributed to 
stabilizing the tRNA on the enzyme (Figure 11). 
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Figure 11: Leucine 855 mutants appear to show some decrease in aminoacylation 
activity.  Aminoacylation reactions were performed in triplicate.  
 
Although the L855 residue pointed away from the tRNA and into a hydrophobic 
pocket, we hypothesized that a backbone interaction was the critical interaction with the 
tRNA. By mutating this residue to a polar amino acid, we anticipated disrupting the 
insertion of its sidechain into the hydrophobic pocket, thereby changing the orientation of 
the backbone. The mutants L855E and L855N appear to show the greatest effect, 
however, this was later found to cause a molecular weight shift on an SDS-PAGE gel. 
We believe that a protease cleavage site was introduced by these mutants. We then 
determined that 1 µM of each mutant enzyme contained equal amounts of the higher 
molecular weight band as did 50 nM of WT enzyme. We then repeated the 
aminoacylation reaction (Figure 12). By normalizing the concentration of total protein 
corresponding to the full-length enzyme, we showed that the lower molecular weight 
band was a contaminant and that the higher molecular weight band aminoacylates with 
the same activity of the wild-type enzyme. 
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Figure 12: Normalized aminoacylation activity of L855 mutants displaying a 
molecular weight shift. Aminoacylation reactions were performed in triplicate. 
 
 
The last amino acid residue we tested was N856. We mutated this residue to 
alanine, aspartic acid, leucine, arginine and glutamine. In each case, there was a modest 
decrease in aminoacylation activity with the greatest loss measured for the N856A 
mutant LeuRS (Figure 13).  
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Figure 13: Aminoacylation activity of N856 mutants. Aminoacylation reactions were 
performed in triplicate. Aminoacylation is modestly affected by an alanine mutation.  
 
Upon examination of the crystal structure, we realized that there might be some 
interaction between the amine group of N856 and the carbonyl of cytosine 56 on the 
tRNA, as these two groups are ~2.8 Å apart. We swapped the guanine 19 and cytosine 
57 bases on the tRNA, making the 19 position a cytosine and the 57 position a guanine. 
While the initial reaction rate overlapped, wild-type LeuRS charged the mutant tRNALeu to 
a lower plateau level (Figure 14). It is possible that the base stacking in this region is 
likely preserved, facilitating interactions between the amine from the carbonyl of the 
guanine at position 57 and the asparagine residue. It is also possible that tRNA folding is 
de-stabilized by the critical backbone interaction in the tertiary structure.  In this case, a 
fraction of the tRNA may not be folded competently for aminoacylation. 
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Figure 14: Aminoacylation reaction with “swapped” GC base pair. Aminoacylation 
reactions were performed in triplicate. Aminoacylation burst velocity appears un affected, 
however effects can be seen by the decreased plateau. 
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Discussion   
 
Previous research from our group demonstrated that the C-terminal domain is 
essential for the aminoacylation and editing reactions. From this previous study, we 
believe that the C-terminal domain stabilizes the tRNA on the enzyme during both 
reactions. Alanine scanning of conserved amino acids and residues corresponding to 
hydrogen bonds between the enzyme and the tRNA failed to highlight specific 
mechanisms of tRNA stabilization. 
In contrast to the previous study, this project was greatly aided by the co-crystal 
structure of E. coli LeuRS and computational community network analysis. However, we 
mutation of these additional residues or tRNA identity elements only modestly 
contributed to LeuRS aminoacylation of its cognate tRNA.  
It is likely that the coevolution of LeuRS and its tRNA substrate, meaning, the 
critical G19-C57 bonding which creates the elbow of the tRNA, can sufficiently 
compensate for the amide-carbonyl bond between the tRNA and the enzyme to achieve 
aminoacylation, albeit the plateau levels of charging activity were decreased. This is 
consistent with previous proposals (John J Perona & Hou, 2007) that the enzyme 
recognizes the shape of the tRNA rather than a specific identity element. Changing the 
G19-C57 to an AU pair or a mismatched pair would be expected to disrupt the structure 
of the tRNA, so this limits the ways to test the importance of the amide-carbonyl 
interaction.  
The interior region of the C-terminal domain excludes water molecules, so many 
of the residues, including L855, interact with the environment via backbone interactions. 
Our mutational analysis approach was thus unable to test whether this backbone 
interaction is important to tRNA stabilization. As backbone mutagenesis becomes more 
standard practice, this will be a very interesting hypothesis to test.  
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Although these mutations resulted in only modest results, it speaks to how 
amazing the co-evolution is between the LeuRS and its tRNA substrate. By relying on 
backbone interactions for between the cognate tRNALeu and LeuRS, mutations within the 
LeuRS C-terminal domain, there would be minimal effects to the cell.  
In a similar fashion, the G19:C57 pairing in the tRNA is essential to tRNA shape, 
which affects aminoacylation and translation. By relying on the shape of the tRNA for its 
interaction with LeuRS rather than its specific sequence, this allows the tRNA to tolerate 
a wider range of mutations before rendering it ineffective. 
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Appendix: Supplementary Figures 
>C.	elegans	mitochondrial	LeuRS	chromosomal	DNA	sequence	
5’-
ATGTTACGATGGGGTACCATTCAGCAGATCCGTCGAATTGGATCAGCACTTCAGTGGCCGTTGAAGGACATCCGGATC
AGTGAAAATACAAAAATGCTGGAGAAACATTGGTCAAAATCACTTGTCGATTCTTTTGAATCTTCAAAAAATgtaggg
aattttcatttataattgagtctatagattataataaaaattaggaaaataaatttagaaagtttatttctaaactac
aattaatatttttagAAACCCAGCAATCTCAATGGAAAGAAATATATTCTATCAATGTTTCCATATCCATCAGGACGA
CTTCATATTGGCCATATGAGAGTTTATACAATCTCAGATGCAACTGCTCGGTATTATCGTTTAAATGGATATGAAGTG
ATACATCCGATCGGATGGGACTCTTTTGGATTACCAGCAGAGAATGCAGCAAGAGACAAAGGAGTTGATCCAAGAGAA
TGGACTATTAATAATATTGAATCAATGAAACAACAACTCTTAAAAACCAAGATTTTATTTGATTGGGAGAAAGAAATT
TCAACGTGTGAACCTGAATTTTTCCGTTGGACACAATGGATTTTTTGTAAACTTTTTGAGTACGGACTGGTGAAACGA
ACATCTTCGGAAGTTAATTGGGATCCAATCGATAAAACTGTTCTGGCTGCTGAACAAATAGATAACGATGGAAAAAGT
TGGAGAAGTGGAGCGAAAGCTGAAAAGAAGAAGCTTAGCCAATGGATGATTGAAACGCCAAAATATGCAAAAAGACTA
CAAGAAGGTTTAAGAAAAATGTCTGAACAATGGGGAGAAGTTGCTGATATTCAAGCTAATTGGATCGGAAAATGTGAT
GTTTATCGGTTTATGTTGCCTGTTATGAAGGATGGATCAAACGATGAAATTATTGATTTGAGAATCAAAGATATCTTT
GAAATTTCAAATGCCGAATTTTTGGTTTTGAAGCAAAGTCACTCGTTGGCAGACAAGGATGCCACGCAGTTTCCATgt
aagttctcgtttcatcggaaagtaattgttttaattattggaactgaatctagaatttatttatggaaatttcaaaca
aataatatactcgctcaaattttcagACAAACTTCCGTTTCAAGTTTTGAACGGAGTAACAGGCCGTCAAATACCAGT
CATTGTAGTGGAAGACACATATCAACCAGATGTCACAAGCTTCTTGAACTCGAGAATTGGAAACTTTCAGAAAGACAA
AATTCTTGTCGAAAAGTTTGCGATAGCTGAGCCGAAACACAAAAGAAAGTTGACGAAGAATGATATTCAGGAGATGGC
ATCGgtaacacacgattacgggatccggtcacgacgcgactgaaaatttttccgtgaaagagtgtgcgcctttaaaaa
gtacggttcactacatccagattttcgcaatttttatcgatttttcatcgacttttcccttaaagccaaccaaaaaca
ggaagttgcaattacagtactcgagaaaggtatacaccgtttttctcagaaattttcagccgtttcgagaccggatac
cgtaatttttcctcaaaaatcgcattttgtagaaaatggataataagcgaatgtgttattttctgcaactttttcaag
aaaaatattcaaaaagcgttcacaaatgccaacaattttcagTTTGGTGGATACGGTGGCTATGAAACATCCCGAACG
TTAACAGATTGGGTTGTGAGTCGTCAACGTGGATGGGGAACTCCAATTCCAATGATCCAAACCAAAGACGGAAAACGA
GTTGCTGTTCAATTAAATAAACTTCCAGTCCTTGGGTCAGATCGCGGGCAAGAAGTAGATAAAGAAAGATTCGGAGAA
TCCGGAGTATTCGACACAGATACTCTTGATACATTCTTTGATTCTGCATGgtagagtatatatctgaaatgtacattt
ggattaaacttgaatatttttagGTACTATCTTCGATACCTTGACAACAAAAATAAAAGCGAATTGATTTCCAAAGGA
GCAATGAAGAATATGCCTGTTGATGTCTATGTTGGAGGAATTGAACACGCAGCGGTGCACATGTTTTTTGCTAGATTT
GTTGCATATTTCTTGAAGGATATCAATGTTATCCAGgttggtaaaaactatcatttttaggtttaatcaaaatttaac
attttccagACAGCTGAACCATTCACTGACCTCATCCCACAAGGAATTGTTCGGGGAAAGACGTTCATCGAAAAAGAA
ACAGGAAAATATCTTGGATCAGAAGATGTTCAACAATCTGGAGATAAACTCACATTGAAGAATGATTCATCTGTTGAA
GTTGACGCTGTCTATGAAAAGATGAGCAAATCGAAAAACAACGGCGTAGATTTGGCTGCAATTTTGGATTCGGAAGGA
GTTGATATGACAAGACTTAGATTACTTGAAGCTGCAGCTCCGAGAGCTCCCATTAATTGGGGCGAAACAGATTTAAAG
GGAATCAAGAAACTTTTGGATCGAATTGCGGCAATCAATTCGCAAATTGTTGATGCACGAGATAATGGAAAACCAATA
GAGTTGAAGAAAGAAATTGATGGAAGTATAAAAGAAACATATAACTTTTTCGTAAGAAATGTTGGAATGTGTCTAGAA
GTACTTCATCTTCATAATACTGCGTTGATGAGAATACAGGGATTCACTAATGCATTAAAGgttatttaacaaatattt
ttaaagtctgaaatgatgttttgatatcactttttaaagaaaaaaaccacaaactaaaatgatttatttcagAAAGTT
GATCCAATCTACCTGGCTCACAGCCCAGAAGGCCAACGAGCGGTGAAATCGTTGATTATTATGCTTCAAgtagttttt
aagttctaaagtgcaatctgttcattaattttctagGTTTTTTGTCCACACGTCGCTTCCGAAATGTGTCAGCATTAG
CTAATGATGGTTCACTGGTTTCCGATCAAAAGTGGCCCGAAGTTGATAAAGATGCTGATATTGAATTTCTTCTGATGA
TTGATGGTGTTAGTGGTGGTAGGCCTTCTCTTGATCGGCGGATTATTGAAGAAATGTCTATGGATCAGTTATGGGAAC
GAGCTACATTTTATGAACACGCAGATATTCTTCGAATGATGAAAGAAGATGGAATGAAGCTGAAAAATTCAAGTTATA
TTTCTAGGAAAGgttaggttttgtctgtctagttaccaactttagattacaataagaaatctaagttattaagttatt
aacaaattttcagGTTTCCACGTAACTCTATCGTGTAGCTTGGAAGGTGACAAAGAAGAGAACCGCAAGAAAATTGGC
AAAATTCTGGACAGAATTCAAGCAGAGAAGAGAAAGTTGGAAATCGGGAAGAAAGGTGGAAAGAGGAAGAAAGAAAAG
AAGATTGTGAATAAGTGActtattttactggagaacattagtttaatttttaacagttttgaaatatatattagctta
gaaataggttgttgttttattgttttctgaataatttttatatttacgggcttgtttattgtttttcatgaaaataaa
tttgttgagtga	–	3’	
Figure A.1: C. elegans mitochondrial LeuRS chromosomal sequence.	Exons 
shown in upper case. Introns and 3’ untranslated region shown in lower case.  
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>C.	elegans	mitochondrial	LeuRS	chromosomal	sequence	without	introns 
	
ATGTTACGATGGGGTACCATTCAGCAGATCCGTCGAATTGGATCAGCACTTCAGTGGCCGTTGAAGGACAT
CCGGATCAGTGAAAATACAAAAATGCTGGAGAAACATTGGTCAAAATCACTTGTCGATTCTTTTGAATCTT
CAAAAAATAAACCCAGCAATCTCAATGGAAAGAAATATATTCTATCAATGTTTCCATATCCATCAGGACGA
CTTCATATTGGCCATATGAGAGTTTATACAATCTCAGATGCAACTGCTCGGTATTATCGTTTAAATGGATA
TGAAGTGATACATCCGATCGGATGGGACTCTTTTGGATTACCAGCAGAGAATGCAGCAAGAGACAAAGGAG
TTGATCCAAGAGAATGGACTATTAATAATATTGAATCAATGAAACAACAACTCTTAAAAACCAAGATTTTA
TTTGATTGGGAGAAAGAAATTTCAACGTGTGAACCTGAATTTTTCCGTTGGACACAATGGATTTTTTGTAA
ACTTTTTGAGTACGGACTGGTGAAACGAACATCTTCGGAAGTTAATTGGGATCCAATCGATAAAACTGTTC
TGGCTGCTGAACAAATAGATAACGATGGAAAAAGTTGGAGAAGTGGAGCGAAAGCTGAAAAGAAGAAGCTT
AGCCAATGGATGATTGAAACGCCAAAATATGCAAAAAGACTACAAGAAGGTTTAAGAAAAATGTCTGAACA
ATGGGGAGAAGTTGCTGATATTCAAGCTAATTGGATCGGAAAATGTGATGTTTATCGGTTTATGTTGCCTG
TTATGAAGGATGGATCAAACGATGAAATTATTGATTTGAGAATCAAAGATATCTTTGAAATTTCAAATGCC
GAATTTTTGGTTTTGAAGCAAAGTCACTCGTTGGCAGACAAGGATGCCACGCAGTTTCCATACAAACTTCC
GTTTCAAGTTTTGAACGGAGTAACAGGCCGTCAAATACCAGTCATTGTAGTGGAAGACACATATCAACCAG
ATGTCACAAGCTTCTTGAACTCGAGAATTGGAAACTTTCAGAAAGACAAAATTCTTGTCGAAAAGTTTGCG
ATAGCTGAGCCGAAACACAAAAGAAAGTTGACGAAGAATGATATTCAGGAGATGGCATCGTTTGGTGGATA
CGGTGGCTATGAAACATCCCGAACGTTAACAGATTGGGTTGTGAGTCGTCAACGTGGATGGGGAACTCCAA
TTCCAATGATCCAAACCAAAGACGGAAAACGAGTTGCTGTTCAATTAAATAAACTTCCAGTCCTTGGGTCA
GATCGCGGGCAAGAAGTAGATAAAGAAAGATTCGGAGAATCCGGAGTATTCGACACAGATACTCTTGATAC
ATTCTTTGATTCTGCATGGTACTATCTTCGATACCTTGACAACAAAAATAAAAGCGAATTGATTTCCAAAG
GAGCAATGAAGAATATGCCTGTTGATGTCTATGTTGGAGGAATTGAACACGCAGCGGTGCACATGTTTTTT
GCTAGATTTGTTGCATATTTCTTGAAGGATATCAATGTTATCCAGACAGCTGAACCATTCACTGACCTCAT
CCCACAAGGAATTGTTCGGGGAAAGACGTTCATCGAAAAAGAAACAGGAAAATATCTTGGATCAGAAGATG
TTCAACAATCTGGAGATAAACTCACATTGAAGAATGATTCATCTGTTGAAGTTGACGCTGTCTATGAAAAG
ATGAGCAAATCGAAAAACAACGGCGTAGATTTGGCTGCAATTTTGGATTCGGAAGGAGTTGATATGACAAG
ACTTAGATTACTTGAAGCTGCAGCTCCGAGAGCTCCCATTAATTGGGGCGAAACAGATTTAAAGGGAATCA
AGAAACTTTTGGATCGAATTGCGGCAATCAATTCGCAAATTGTTGATGCACGAGATAATGGAAAACCAATA
GAGTTGAAGAAAGAAATTGATGGAAGTATAAAAGAAACATATAACTTTTTCGTAAGAAATGTTGGAATGTG
TCTAGAAGTACTTCATCTTCATAATACTGCGTTGATGAGAATACAGGGATTCACTAATGCATTAAAGAAAG
TTGATCCAATCTACCTGGCTCACAGCCCAGAAGGCCAACGAGCGGTGAAATCGTTGATTATTATGCTTCAA
GTTTTTTGTCCACACGTCGCTTCCGAAATGTGGTCAGCATTAGCTAATGATGGTTCACTGGTTTCCGATCA
AAAGTGGCCCGAAGTTGATAAAGATGCTGATATTGAATTTCTTCTGATGATTGATGGTGTTAGTGGTGGTA
GGCCTTCTCTTGATCGGCGGATTATTGAAGAAATGTCTATGGATCAGTTATGGGAACGAGCTACATTTTAT
GAACACGCAGATATTCTTCGAATGATGAAAGAAGATGGAATGAAGCTGAAAAATTCAAGTTATATTTCTAG
GAAAGGTTTCCACGTAACTCTATCGTGTAGCTTGGAAGGTGACAAAGAAGAGAACCGCAAGAAAATTGGCA
AAATTCTGGACAGAATTCAAGCAGAGAAGAGAAAGTTGGAAATCGGGAAGAAAGGTGGAAAGAGGAAGAAA
GAAAAGAAGATTGTGAATAAGTGActtattttactggagaacattagtttaatttttaacagttttgaaat
atatattagcttagaaataggttgttgttttattgttttctgaataatttttatatttacgggcttgttta
ttgtttttcatgaaaataaatttgttgagtga	
Figure A.2: Mitochondrial LeuRS of C. elegans DNA sequence without introns: 
Exons shown in upper case, 3’ untranslated region shown in lower case. 
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>C.	elegans	mitochondrial	LeuRS	splice	variant	DNA	sequence	
	
aacttccgtttcaagttttgaacggagtaacaggccgtcaaataccagtcattgtagtggaagacacatat
caaccagatgtcacaagcttcttgaactcgagaattggaaactttcagaaagacaaaattcttgtcgaaaa
gtttgcgatagctgagccgaaacacaaaagaaagttgacgaagaatgatattcaggagatggcatcggtaa
cacacgattacgggatccggtcacgacgcgactgaaaatttttccgtgaaagagtgtgcgcctttaaaaag
tacggttcactacatccagattttcgcaatttttatcgatttttcatcgacttttcccttaaagccaacca
aaaacaggaagttgcaattacagtactcgagaaaggtatacaccgtttttctcagaaattttcagccgttt
cgagaccggataccgtaatttttcctcaaaaatcgcattttgtagaaaatggataataagcgaatgtgtta
ttttctgcaactttttcaagaaaaatattcaaaaagcgttcacaaatgccaacaattttcagtttggtgga
tacggtggctatgaaacatcccgaacgttaacagattgggttgtgagtcgtcaacgtggatggggaactcc
aattccaATGATCCAAACCAAAGACGGAAAACGAGTTGCTGTTCAATTAAATAAACTTCCAGTCCTTGGGT
CAGATCGCGGGCAAGAAGTAGATAAAGAAAGATTCGGAGAATCCGGAGTATTCGACACAGATACTCTTGAT
ACATTCTTTGATTCTGCATGgtagagtatatatctgaaatgtacatttggattaaacttgaatatttttag
GTACTATCTTCGATACCTTGACAACAAAAATAAAAGCGAATTGATTTCCAAAGGAGCAATGAAGAATATGC
CTGTTGATGTCTATGTTGGAGGAATTGAACACGCAGCGGTGCACATGTTTTTTGCTAGATTTGTTGCATAT
TTCTTGAAGGATATCAATGTTATCCAGgttggtaaaaactatcatttttaggtttaatcaaaatttaacat
tttccagACAGCTGAACCATTCACTGACCTCATCCCACAAGGAATTGTTCGGGGAAAGACGTTCATCGAAA
AAGAAACAGGAAAATATCTTGGATCAGAAGATGTTCAACAATCTGGAGATAAACTCACATTGAAGAATGAT
TCATCTGTTGAAGTTGACGCTGTCTATGAAAAGATGAGCAAATCGAAAAACAACGGCGTAGATTTGGCTGC
AATTTTGGATTCGGAAGGAGTTGATATGACAAGACTTAGATTACTTGAAGCTGCAGCTCCGAGAGCTCCCA
TTAATTGGGGCGAAACAGATTTAAAGGGAATCAAGAAACTTTTGGATCGAATTGCGGCAATCAATTCGCAA
ATTGTTGATGCACGAGATAATGGAAAACCAATAGAGTTGAAGAAAGAAATTGATGGAAGTATAAAAGAAAC
ATATAACTTTTTCGTAAGAAATGTTGGAATGTGTCTAGAAGTACTTCATCTTCATAATACTGCGTTGATGA
GAATACAGGGATTCACTAATGCATTAAAGgttatttaacaaatatttttaaagtctgaaatgatgttttga
tatcactttttaaagaaaaaaaccacaaactaaaatgatttatttcagAAAGTTGATCCAATCTACCTGGC
TCACAGCCCAGAAGGCCAACGAGCGGTGAAATCGTTGATTATTATGCTTCAAgtagtttttaagttctaaa
gtgcaatctgttcattaattttctagGTTTTTTGTCCACACGTCGCTTCCGAAATGTGGTCAGCATTAGCT
AATGATGGTTCACTGGTTTCCGATCAAAAGTGGCCCGAAGTTGATAAAGATGCTGATATTGAATTTCTTCT
GATGATTGATGGTGTTAGTGGTGGTAGGCCTTCTCTTGATCGGCGGATTATTGAAGAAATGTCTATGGATC
AGTTATGGGAACGAGCTACATTTTATGAACACGCAGATATTCTTCGAATGATGAAAGAAGATGGAATGAAG
CTGAAAAATTCAAGTTATATTTCTAGGAAAGgttaggttttgtctgtctagttaccaactttagattacaa
taagaaatctaagttattaagttattaacaaattttcagGTTTCCACGTAACTCTATCGTGTAGCTTGGAA
GGTGACAAAGAAGAGAACCGCAAGAAAATTGGCAAAATTCTGGACAGAATTCAAGCAGAGAAGAGAAAGTT
GGAAATCGGGAAGAAAGGTGGAAAGAGGAAGAAAGAAAAGAAGATTGTGAATAAGTGActtattttactgg
agaacattagtttaatttttaacagttttgaaatatatattagcttagaaataggttgttgttttattgtt
ttctgaataatttttatatttacgggcttgtttattgtttttcatgaaaataaatttgtt	
Figure A.3: Chromosomal DNA sequence of C. elegans mtLeuRS splice-variant. 
Exons shown in upper case. Introns and 3’ untranslated region shown in lower case. 
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>C.	elegans	mitochondrial	LeuRS	splice-variant	sequence	without	introns	
	
aacttccgtttcaagttttgaacggagtaacaggccgtcaaataccagtcattgtagtggaagacacatat
caaccagatgtcacaagcttcttgaactcgagaattggaaactttcagaaagacaaaattcttgtcgaaaa
gtttgcgatagctgagccgaaacacaaaagaaagttgacgaagaatgatattcaggagatggcatcgtggt
ggatacggtggctatgaaacatcccgaacgttaacagattgggttgtgagtcgtcaacgtggatggggaac
tccaattccaATGATCCAAACCAAAGACGGAAAACGAGTTGCTGTTCAATTAAATAAACTTCCAGTCCTTG
GGTCAGATCGCGGGCAAGAAGTAGATAAAGAAAGATTCGGAGAATCCGGAGTATTCGACACAGATACTCTT
GATACATTCTTTGATTCTGCATGGTACTATCTTCGATACCTTGACAACAAAAATAAAAGCGAATTGATTTC
CAAAGGAGCAATGAAGAATATGCCTGTTGATGTCTATGTTGGAGGAATTGAACACGCAGCGGTGCACATGT
TTTTTGCTAGATTTGTTGCATATTTCTTGAAGGATATCAATGTTATCCAGACAGCTGAACCATTCACTGAC
CTCATCCCACAAGGAATTGTTCGGGGAAAGACGTTCATCGAAAAAGAAACAGGAAAATATCTTGGATCAGA
AGATGTTCAACAATCTGGAGATAAACTCACATTGAAGAATGATTCATCTGTTGAAGTTGACGCTGTCTATG
AAAAGATGAGCAAATCGAAAAACAACGGCGTAGATTTGGCTGCAATTTTGGATTCGGAAGGAGTTGATATG
ACAAGACTTAGATTACTTGAAGCTGCAGCTCCGAGAGCTCCCATTAATTGGGGCGAAACAGATTTAAAGGG
AATCAAGAAACTTTTGGATCGAATTGCGGCAATCAATTCGCAAATTGTTGATGCACGAGATAATGGAAAAC
CAATAGAGTTGAAGAAAGAAATTGATGGAAGTATAAAAGAAACATATAACTTTTTCGTAAGAAATGTTGGA
ATGTGTCTAGAAGTACTTCATCTTCATAATACTGCGTTGATGAGAATACAGGGATTCACTAATGCATTAAA
GAAAGTTGATCCAATCTACCTGGCTCACAGCCCAGAAGGCCAACGAGCGGTGAAATCGTTGATTATTATGC
TTCAAGTTTTTTGTCCACACGTCGCTTCCGAAATGTGGTCAGCATTAGCTAATGATGGTTCACTGGTTTCC
GATCAAAAGTGGCCCGAAGTTGATAAAGATGCTGATATTGAATTTCTTCTGATGATTGATGGTGTTAGTGG
TGGTAGGCCTTCTCTTGATCGGCGGATTATTGAAGAAATGTCTATGGATCAGTTATGGGAACGAGCTACAT
TTTATGAACACGCAGATATTCTTCGAATGATGAAAGAAGATGGAATGAAGCTGAAAAATTCAAGTTATATT
TCTAGGAAAGGTTTCCACGTAACTCTATCGTGTAGCTTGGAAGGTGACAAAGAAGAGAACCGCAAGAAAAT
TGGCAAAATTCTGGACAGAATTCAAGCAGAGAAGAGAAAGTTGGAAATCGGGAAGAAAGGTGGAAAGAGGA
AGAAAGAAAAGAAGATTGTGAATAAGTGActtattttactggagaacattagtttaatttttaacagtttt
gaaatatatattagcttagaaataggttgttgttttattgttttctgaataatttttatatttacgggctt
gtttattgtttttcatgaaaataaatttgtt	
Figure A.4: Splice-variant of C. elegans mitochondrial LeuRS DNA sequence 
without introns: Exons shown in upper case, 3’ untranslated region shown in lower 
case. 
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>C.	elegans	chromosomal	CECL	sequence	
	
GGTTTCCACGTAACTCTATCGTGTAGCTTGGAAGGTGACAAAGAAGAGAACCGCAAGAAAATTGGCAAAAT
TCTGGACAGAATTCAAGCAGAGAAGAGAAAGTTGGAAATCGGGAAGAAAGGTGGAAAGAGGAAGAAAGAAA
AGAAGATTGTGAATAAGTGA	
Figure A.5: Chromosomal DNA sequence of C. elegans CECL sequence.  
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>C.	elegans	mitochondrial	LeuRS	codon	optimized	DNA	sequence	
	
ATGCTGCGTTGGGGCACCATTCAGCAGATTCGTCGTATTGGTAGTGCCCTGCAGTGGCCTCTGAAAGATAT
TCGTATTAGCGAAAACACCAAAATGCTGGAAAAACATTGGAGCAAAAGCCTGGTTGATAGCTTTGAAAGCA
GCAAAAACAAACCGAGCAATCTGAACGGCAAAAAATACATCCTGAGCATGTTTCCGTATCCGAGCGGTCGT
CTGCATATTGGTCATATGCGTGTTTATACCATTAGTGATGCAACCGCACGTTATTATCGTCTGAATGGTTA
TGAAGTGATTCATCCGATTGGTTGGGATAGTTTTGGTCTGCCTGCAGAAAATGCAGCACGTGATAAAGGTG
TTGATCCGCGTGAATGGACCATTAATAACATCGAAAGCATGAAACAGCAACTGCTGAAAACCAAAATCCTG
TTCGATTGGGAAAAAGAGATTAGTACCTGCGAACCGGAATTTTTTCGTTGGACCCAGTGGATTTTTTGCAA
ACTGTTTGAATATGGTCTGGTGAAACGTACCAGCAGCGAAGTTAATTGGGATCCGATTGATAAAACCGTTC
TGGCAGCAGAGCAGATTGATAATGATGGTAAAAGCTGGCGTAGCGGTGCAAAAGCAGAGAAAAAAAAACTG
AGCCAGTGGATGATTGAAACCCCGAAATATGCAAAACGTCTGCAAGAGGGTCTGCGTAAAATGAGCGAACA
GTGGGGTGAAGTTGCAGATATTCAGGCAAATTGGATTGGCAAATGTGATGTGTATCGTTTTATGCTGCCGG
TGATGAAAGATGGTAGCAACGATGAAATTATTGATCTGCGCATCAAAGACATCTTCGAAATTAGCAATGCC
GAATTCCTGGTTCTGAAACAGAGCCATAGCCTGGCAGATAAAGATGCAACCCAGTTTCCTTATAAACTGCC
GTTTCAGGTTCTGAATGGCGTTACCGGTCGTCAGATTCCGGTTATTGTTGTTGAAGATACCTATCAGCCGG
ATGTTACCAGCTTTCTGAATAGCCGCATTGGCAATTTCCAGAAAGATAAAATCCTGGTGGAAAAATTTGCA
ATCGCGGAACCGAAACATAAACGCAAACTGACCAAAAACGATATCCAAGAAATGGCAAGCTTTGGTGGTTA
TGGTGGCTATGAAACCAGCCGTACCCTGACCGATTGGGTTGTTAGCCGTCAGCGTGGTTGGGGTACACCGA
TTCCGATGATTCAGACCAAAGATGGCAAACGTGTTGCAGTGCAGCTGAACAAACTGCCGGTTCTGGGTAGC
GATCGTGGTCAAGAAGTTGATAAAGAACGTTTTGGTGAAAGCGGTGTGTTTGATACCGATACCCTGGATAC
CTTTTTTGATAGCGCATGGTATTATCTGCGCTACCTGGACAATAAAAACAAAAGCGAACTGATTAGCAAAG
GTGCCATGAAAAATATGCCGGTGGATGTTTATGTTGGTGGTATTGAACATGCAGCCGTGCATATGTTTTTT
GCACGTTTTGTTGCCTATTTTCTGAAAGACATCAATGTGATCCAGACCGCAGAACCGTTTACCGATCTGAT
TCCGCAGGGTATTGTTCGTGGTAAAACCTTTATTGAAAAAGAAACCGGCAAATATCTGGGCAGCGAAGATG
TTCAGCAGAGCGGTGATAAACTGACCCTGAAAAATGATAGCAGCGTTGAAGTTGATGCCGTGTATGAAAAA
ATGTCCAAATCCAAAAATAACGGCGTTGATCTGGCAGCCATTCTGGATAGCGAAGGTGTGGATATGACCCG
TCTGCGTCTGCTGGAAGCAGCAGCACCGCGTGCACCGATTAATTGGGGTGAAACGGATCTGAAAGGGATCA
AAAAACTGCTGGATCGTATTGCAGCAATTAACAGCCAGATTGTTGATGCCCGTGATAATGGTAAACCGATC
GAACTGAAAAAAGAAATCGATGGCAGCATTAAAGAAACCTACAACTTTTTTGTGCGCAATGTTGGTATGTG
TCTGGAAGTTCTGCATCTGCATAATACCGCACTGATGCGTATTCAGGGCTTTACCAATGCCCTGAAAAAAG
TGGATCCGATTTATCTGGCACATAGTCCGGAAGGTCAGCGTGCAGTTAAAAGCCTGATTATTATGCTGCAG
GTTTTTTGTCCGCATGTGGCAAGCGAAATGTGGTCAGCACTGGCAAATGATGGTTCACTGGTTAGCGATCA
GAAATGGCCTGAGGTTGACAAAGATGCCGATATTGAATTTCTGCTGATGATTGATGGTGTTAGCGGTGGTC
GTCCGAGCCTGGATCGTCGCATTATTGAAGAAATGAGCATGGATCAGCTGTGGGAACGTGCAACCTTTTAT
GAACATGCGGATATTCTGCGCATGATGAAAGAAGATGGTATGAAACTGAAAAACAGCAGCTATATTTCCCG
CAAAGGTTTTCATGTTACCCTGAGCTGTAGCCTGGAAGGCGATAAAGAAGAAAATCGCAAAAAAATCGGCA
AAATTCTGGATCGCATTCAGGCCGAAAAACGTAAACTGGAAATCGGTAAAAAAGGCGGTAAACGTAAAAAA
GAGAAAAAAATCGTTAACAAATAA	
Figure A.6: Codon optimized sequence of C. elegans mitochondrial LeuRS. 
Optimized for use in E. coli expression.  
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>C.	elegans	mitochondrial	LeuRS	splice-variant	codon	optimized	sequence	
	
ATGATTCAGACCAAAGATGGCAAACGTGTTGCAGTGCAGCTGAACAAACTGCCGGTTCTGGGTAGCGATCG
TGGTCAAGAAGTTGATAAAGAACGTTTTGGTGAAAGCGGTGTGTTTGATACCGATACCCTGGATACCTTTT
TTGATAGCGCATGGTATTATCTGCGCTACCTGGACAATAAAAACAAAAGCGAACTGATTAGCAAAGGTGCC
ATGAAAAATATGCCGGTGGATGTTTATGTTGGTGGTATTGAACATGCAGCCGTGCATATGTTTTTTGCACG
TTTTGTTGCCTATTTTCTGAAAGACATCAATGTGATCCAGACCGCAGAACCGTTTACCGATCTGATTCCGC
AGGGTATTGTTCGTGGTAAAACCTTTATTGAAAAAGAAACCGGCAAATATCTGGGCAGCGAAGATGTTCAG
CAGAGCGGTGATAAACTGACCCTGAAAAATGATAGCAGCGTTGAAGTTGATGCCGTGTATGAAAAAATGTC
CAAATCCAAAAATAACGGCGTTGATCTGGCAGCCATTCTGGATAGCGAAGGTGTGGATATGACCCGTCTGC
GTCTGCTGGAAGCAGCAGCACCGCGTGCACCGATTAATTGGGGTGAAACGGATCTGAAAGGGATCAAAAAA
CTGCTGGATCGTATTGCAGCAATTAACAGCCAGATTGTTGATGCCCGTGATAATGGTAAACCGATCGAACT
GAAAAAAGAAATCGATGGCAGCATTAAAGAAACCTACAACTTTTTTGTGCGCAATGTTGGTATGTGTCTGG
AAGTTCTGCATCTGCATAATACCGCACTGATGCGTATTCAGGGCTTTACCAATGCCCTGAAAAAAGTGGAT
CCGATTTATCTGGCACATAGTCCGGAAGGTCAGCGTGCAGTTAAAAGCCTGATTATTATGCTGCAGGTTTT
TTGTCCGCATGTGGCAAGCGAAATGTGGTCAGCACTGGCAAATGATGGTTCACTGGTTAGCGATCAGAAAT
GGCCTGAGGTTGACAAAGATGCCGATATTGAATTTCTGCTGATGATTGATGGTGTTAGCGGTGGTCGTCCG
AGCCTGGATCGTCGCATTATTGAAGAAATGAGCATGGATCAGCTGTGGGAACGTGCAACCTTTTATGAACA
TGCGGATATTCTGCGCATGATGAAAGAAGATGGTATGAAACTGAAAAACAGCAGCTATATTTCCCGCAAAG
GTTTTCATGTTACCCTGAGCTGTAGCCTGGAAGGCGATAAAGAAGAAAATCGCAAAAAAATCGGCAAAATT
CTGGATCGCATTCAGGCCGAAAAACGTAAACTGGAAATCGGTAAAAAAGGCGGTAAACGTAAAAAAGAGAA
AAAAATCGTTAACAAATAA	
Figure A.7: Codon optimized DNA sequence of splice-variant of C. elegans 
mitochondrial LeuRS. Optimized for use in E. coli expression.  
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 57 
>C.	elegans	CECL	codon	optimized	DNA	sequence	
	
GGTTTTCATGTTACCCTGAGCTGTAGCCTGGAAGGCGATAAAGAAGAAAATCGCAAAAAAATCGGCAAAAT
TCTGGATCGCATTCAGGCCGAAAAACGTAAACTGGAAATCGGTAAAAAAGGCGGTAAACGTAAAAAAGAGA
AAAAAATCGTTAACAAAtga	
Figure A.8: Codon optimized DNA sequence for C. elegans CECL domain. 
Optimized for use in E. coli expression.  
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 58 
>C.	elegans	mitochondrial	LeuRS	amino	acid	sequence	
	
MLRWGTIQQIRRIGSALQWPLKDIRISENTKMLEKHWSKSLVDSFESSKNKPSNLNGKKYILSMFPYPSGR
LHIGHMRVYTISDATARYYRLNGYEVIHPIGWDSFGLPAENAARDKGVDPREWTINNIESMKQQLLKTKIL
FDWEKEISTCEPEFFRWTQWIFCKLFEYGLVKRTSSEVNWDPIDKTVLAAEQIDNDGKSWRSGAKAEKKKL
SQWMIETPKYAKRLQEGLRKMSEQWGEVADIQANWIGKCDVYRFMLPVMKDGSNDEIIDLRIKDIFEISNA
EFLVLKQSHSLADKDATQFPYKLPFQVLNGVTGRQIPVIVVEDTYQPDVTSFLNSRIGNFQKDKILVEKFA
IAEPKHKRKLTKNDIQEMASFGGYGGYETSRTLTDWVVSRQRGWGTPIPMIQTKDGKRVAVQLNKLPVLGS
DRGQEVDKERFGESGVFDTDTLDTFFDSAWYYLRYLDNKNKSELISKGAMKNMPVDVYVGGIEHAAVHMFF
ARFVAYFLKDINVIQTAEPFTDLIPQGIVRGKTFIEKETGKYLGSEDVQQSGDKLTLKNDSSVEVDAVYEK
MSKSKNNGVDLAAILDSEGVDMTRLRLLEAAAPRAPINWGETDLKGIKKLLDRIAAINSQIVDARDNGKPI
ELKKEIDGSIKETYNFFVRNVGMCLEVLHLHNTALMRIQGFTNALKKVDPIYLAHSPEGQRAVKSLIIMLQ
VFCPHVASEMWSALANDGSLVSDQKWPEVDKDADIEFLLMIDGVSGGRPSLDRRIIEEMSMDQLWERATFY
EHADILRMMKEDGMKLKNSSYISRKGFHVTLSCSLEGDKEENRKKIGKILDRIQAEKRKLEIGKKGGKRKK
EKKIVNK*	
Figure A.9: Amino acid sequence of C. elegans mitochondrial LeuRS. 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 59 
>C.	elegans	mitochondrial	LeuRS	splice-variant	amino	acid	sequence	
	
MIQTKDGKRVAVQLNKLPVLGSDRGQEVDKERFGESGVFDTDTLDTFFDSAWYYLRYLDNKNKSELISKGA
MKNMPVDVYVGGIEHAAVHMFFARFVAYFLKDINVIQTAEPFTDLIPQGIVRGKTFIEKETGKYLGSEDVQ
QSGDKLTLKNDSSVEVDAVYEKMSKSKNNGVDLAAILDSEGVDMTRLRLLEAAAPRAPINWGETDLKGIKK
LLDRIAAINSQIVDARDNGKPIELKKEIDGSIKETYNFFVRNVGMCLEVLHLHNTALMRIQGFTNALKKVD
PIYLAHSPEGQRAVKSLIIMLQVFCPHVASEMWSALANDGSLVSDQKWPEVDKDADIEFLLMIDGVSGGRP
SLDRRIIEEMSMDQLWERATFYEHADILRMMKEDGMKLKNSSYISRKGFHVTLSCSLEGDKEENRKKIGKI
LDRIQAEKRKLEIGKKGGKRKKEKKIVNK	
Figure A.10: Amino acid sequence of C. elegans mitochondrial LeuRS splice-
variant. 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 60 
>C.	elegans	CECL	amino	acid	sequence		
	
GFHVTLSCSLEGDKEENRKKIGKILDRIQAEKRKLEIGKKGGKRKKEKKIVNK	
Figure A.11: Amino acid sequence of C. elegans CECL domain. 
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 61 
 
 
 
Figure A.12: Model of the C. elegans CECL domain: Model made using HHPred. 
HHPred results indicated a large host of similar ubiquitin, ubiquitin-like, and ubiquitin 
ligase proteins. The model strongly resembles the general structure of these proteins.  
